<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-24517" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Lung Nontuberculous Mycobacterial Infections</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bethencourt Mirabal</surname>
            <given-names>Arian</given-names>
          </name>
          <aff>Aventura Hospital and Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Nguyen</surname>
            <given-names>Andrew D.</given-names>
          </name>
          <aff>University of Queensland, University of Western Australia</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ferrer</surname>
            <given-names>Gustavo</given-names>
          </name>
          <aff>Nova Southeastern University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Arian Bethencourt Mirabal declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Andrew Nguyen declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Gustavo Ferrer declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>17</day>
          <month>2</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-24517.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Nontuberculous mycobacteria (NTM) infections are&#x000a0;an underrecognized source of lung disease associated with&#x000a0;severe disease manifestations and mortality, particularly in untreated cases. These mycobacteria cause human disease through environmental aerosol exposure, often related to water systems and soil rather than human-to-human transmission. Following infection, an interaction between the human host and the pathogen may lead to pulmonary disease, including bronchiectasis changes, fibrocavitary disease, and extrapulmonary or disseminated disease. Clinical features, radiological opacities, exclusion of differential diagnoses, and positive microbiology from multiple sputum specimens and other respiratory laboratory studies are primarily used to diagnose nontuberculous mycobacterial lung disease.&#x000a0;</p>
        <p>Appropriate management depends on susceptibility testing, knowledge of first-line antimicrobials and their adverse effect profiles, and the crucial role the multidisciplinary team has in achieving treatment success&#x000a0;for affected patients. This activity reviews the risk factors, assessment, diagnosis, and treatment of&#x000a0;NTM lung infections and highlights the empowering role of the interprofessional, multidisciplinary team in evaluating and treating patients with these infections.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the risk factors related to nontuberculous mycobacterial lung infections.</p></list-item><list-item><p>Identify the typical imaging findings associated with nontuberculous mycobacterial lung infections.</p></list-item><list-item><p>Apply knowledge of the pathophysiology of nontuberculous mycobacterial lung infections&#x000a0;to tailor treatment strategies.&#x000a0;</p></list-item><list-item><p>Collaborate&#x000a0;with the interprofessional&#x000a0;care team to enhance the delivery of patient care.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=24517&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=24517">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-24517.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Nontuberculous mycobacteria (NTM) are ubiquitous in the environment and responsible for opportunistic infections affecting both immunocompromised and immunocompetent hosts.<xref ref-type="bibr" rid="article-24517.r1">[1]</xref>&#x000a0;The incidence of the disease from NTM has been gradually increasing worldwide, becoming, in recent years, an emerging public health problem.<xref ref-type="bibr" rid="article-24517.r2">[2]</xref><xref ref-type="bibr" rid="article-24517.r3">[3]</xref><xref ref-type="bibr" rid="article-24517.r4">[4]</xref>&#x000a0;As a result, various international guidelines, including the American Thoracic Society (ATS) and the British Thoracic Society, have been used to diagnose and manage clinical pulmonary NTM.<xref ref-type="bibr" rid="article-24517.r5">[5]</xref><xref ref-type="bibr" rid="article-24517.r6">[6]</xref>&#x000a0;In 2020, a guideline consensus was released as a collaboration between the ATS, the European Respiratory Society (ERS), the Infectious Diseases Society of America (IDSA), and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID).<xref ref-type="bibr" rid="article-24517.r7">[7]</xref>&#x000a0;</p>
        <p>As new data have led to an increased understanding of pulmonary NTM infections, guidelines continue to be updated to reflect emerging evidence. With new medical advances based on molecular microbiology and the recognition of pulmonary NTM as causing complicated infections, the diagnosis of most NTM is becoming more precise and efficient. This article will summarize and review key features of NTM pulmonary infections, including the epidemiology, clinical features, diagnostic workup, and management of NTM, focusing on the multidisciplinary team approach to improve the clinical care of individuals with NTM pulmonary infections.</p>
      </sec>
      <sec id="article-24517.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Following the discovery of <italic toggle="yes">Mycobacterium tuberculosis</italic> by Robert Koch in 1882, nontuberculous mycobacteria (NTM) have gradually been identified and categorized.<xref ref-type="bibr" rid="article-24517.r8">[8]</xref><xref ref-type="bibr" rid="article-24517.r9">[9]</xref>&#x000a0;The first of these, <italic toggle="yes">Mycobacterium avium</italic>, was first identified in birds and differentiated from tuberculosis by 1890.<xref ref-type="bibr" rid="article-24517.r10">[10]</xref><xref ref-type="bibr" rid="article-24517.r11">[11]</xref>&#x000a0;Further NTM were gradually identified over the years; however, they were not recognized as responsible for human disease until the mid-twentieth&#x000a0;century, upon which classifications were developed to categorize these mycobacteria.<xref ref-type="bibr" rid="article-24517.r12">[12]</xref>&#x000a0;Today, the number of identified NTM species has reached more than 150.<xref ref-type="bibr" rid="article-24517.r13">[13]</xref>&#x000a0;</p>
        <p><italic toggle="yes">M tuberculosis</italic> complex species and NTM are all categorized under the genus <italic toggle="yes">Mycobacterium</italic>. Mycobacteria are typically weakly gram-positive, acid-fast bacilli characterized by mycolic acid-rich cell walls <xref ref-type="bibr" rid="article-24517.r14">[14]</xref>. They typically are of variable length and measure 0.3 to 0.5 &#x003bc;m. Further identification can be made phenotypically based on pigmentation changes in the presence or absence of light (eg, photochromogens, scotochromogens, or nonchromogenic) and growth characteristics, including&#x000a0;the scotochromogenic<italic toggle="yes"> Mycobacterium&#x000a0;szulgai</italic>, <italic toggle="yes">Mycobacterium xenopi</italic>, and <italic toggle="yes">Mycobacterium gordonae</italic>, which can cause pulmonary disease in humans.<xref ref-type="bibr" rid="article-24517.r15">[15]</xref><xref ref-type="bibr" rid="article-24517.r16">[16]</xref>&#x000a0;</p>
        <p>Other identification methods include growth rates, colony variation, biochemical differences, and chromatography. In particular, NTM species that grow in liquid media within 7 days are classed as rapid growers, and those that take more than 2 weeks to grow are slow growers.<xref ref-type="bibr" rid="article-24517.r17">[17]</xref>&#x000a0;However, older phenotypic classifications have been replaced with more advanced molecular and genomic methods for microorganism identification due to more rapid and precise results with these newer modalities.<xref ref-type="bibr" rid="article-24517.r18">[18]</xref>&#x000a0;As a result, further species of NTM can be further discovered and differentiated from existing species due to genomic differences. The most commonly identified pulmonary NTM species in countries&#x000a0;such as&#x000a0;the US, Japan, and French Guiana include <italic toggle="yes">Mycobacterium avium </italic>complex (MAC),&#x000a0;<italic toggle="yes">M gordonae</italic>, <italic toggle="yes">Mycobacteriu<italic toggle="yes">m kansasii</italic></italic>, <italic toggle="yes">Mycobacterium fortuitum,</italic> and&#x000a0;<italic toggle="yes">Mycobacterium abscessus</italic>.<xref ref-type="bibr" rid="article-24517.r19">[19]</xref><xref ref-type="bibr" rid="article-24517.r20">[20]</xref><xref ref-type="bibr" rid="article-24517.r21">[21]</xref>&#x000a0;See <bold>Image.</bold> Mycobacterium Kansasii.</p>
      </sec>
      <sec id="article-24517.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The epidemiology of NTM lung infections has been challenging to determine due to multiple factors, including mandatory reporting to local public health departments not being required in many countries, differentiating between infection and disease often being difficult, unavailable diagnostic testing in all institutions making differentiation between NTM&#x000a0; and tuberculosis infections challenging, and imprecise follow-up&#x000a0;due to the burden of treatment and follow-up of sputum cultures to ensure clearance.<xref ref-type="bibr" rid="article-24517.r22">[22]</xref><xref ref-type="bibr" rid="article-24517.r23">[23]</xref><xref ref-type="bibr" rid="article-24517.r24">[24]</xref><xref ref-type="bibr" rid="article-24517.r2">[2]</xref><xref ref-type="bibr" rid="article-24517.r25">[25]</xref><xref ref-type="bibr" rid="article-24517.r26">[26]</xref></p>
        <p>There is evidence that individuals of Asian and Pacific Islander background may be at increased risk of NTM pulmonary disease.<xref ref-type="bibr" rid="article-24517.r27">[27]</xref>&#x000a0;Part of this may be attributable to a higher incidence of <italic toggle="yes">M tuberculosis</italic> among these populations, given a history of tuberculosis is associated with pulmonary NTM infections due to structural changes.<xref ref-type="bibr" rid="article-24517.r28">[28]</xref><xref ref-type="bibr" rid="article-24517.r29">[29]</xref>&#x000a0;Advanced age, immunosuppression, and the use of corticosteroids are other known risk factors for acquiring these infections.<xref ref-type="bibr" rid="article-24517.r30">[30]</xref></p>
        <p>In the 1980s, US laboratories reported an estimated prevalence of NTM infection of 1 to 2 cases per 100,000 individuals.<xref ref-type="bibr" rid="article-24517.r31">[31]</xref>&#x000a0;The annual prevalence increased among men and women in Florida by 3.2% and 6.5% per year, respectively; in New York, the prevalence in women increased by 4.6% per year. Conversely, there was no significant increase seen in California. The annual prevalence of NTM pulmonary diseases in US Medicare beneficiaries (ie, all persons aged &#x02265;65) increased from 20 per 100,000 in 1997 to 47 per 100,000 in 2007.<xref ref-type="bibr" rid="article-24517.r32">[32]</xref>&#x000a0;Since the initial description of pulmonary NTM in the 1950s, reports of increased incidence and prevalence of pulmonary NTM infections have been documented in Slovakia, the United Kingdom, Ireland, Australia, Japan, South Korea, and the US.<xref ref-type="bibr" rid="article-24517.r33">[33]</xref><xref ref-type="bibr" rid="article-24517.r34">[34]</xref><xref ref-type="bibr" rid="article-24517.r35">[35]</xref><xref ref-type="bibr" rid="article-24517.r36">[36]</xref><xref ref-type="bibr" rid="article-24517.r37">[37]</xref><xref ref-type="bibr" rid="article-24517.r38">[38]</xref>&#x000a0;In Queensland, Australia, where NTM is reportable, the incidence of clinically significant pulmonary disease rose from 2.2 per 100,000 in 1999 to 3.2 per 100,000 in 2005.<xref ref-type="bibr" rid="article-24517.r39">[39]</xref></p>
        <p>While the prevalence and incidence of NTM pulmonary disease have been increasing through the years, not only in the US but also around the world, this epidemiological variation has not been fully explained. Increased awareness among treating clinicians has been proposed as a reason for increased incidence, along with an increasingly aging and comorbid population among high-income countries.<xref ref-type="bibr" rid="article-24517.r40">[40]</xref>&#x000a0;Environmental associations have also been postulated, with increased population exposure to plumbing, indoor swimming pools, high rainfall events, and disruption of local soil being linked with a higher risk of NTM infections.<xref ref-type="bibr" rid="article-24517.r37">[37]</xref>&#x000a0;<xref ref-type="bibr" rid="article-24517.r41">[41]</xref><xref ref-type="bibr" rid="article-24517.r42">[42]</xref><xref ref-type="bibr" rid="article-24517.r43">[43]</xref><xref ref-type="bibr" rid="article-24517.r44">[44]</xref>&#x000a0;Hot tubs themselves have been clinically linked with cases of MAC.<xref ref-type="bibr" rid="article-24517.r45">[45]</xref>&#x000a0;New radiological advances, especially resolution chest computed tomography (CT) scanning, improved diagnosis, and increased chest screening may also be important factors responsible for these epidemiological observations.<xref ref-type="bibr" rid="article-24517.r46">[46]</xref><xref ref-type="bibr" rid="article-24517.r47">[47]</xref>&#x000a0;See <bold>Image.</bold> Chest&#x000a0;CT of&#x000a0;<italic toggle="yes">Mycobacterium Abscessus.</italic></p>
      </sec>
      <sec id="article-24517.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Nontuberculous mycobacterium may cause disease de novo in healthy human hosts; however, the pulmonary disease is commonly implicated in individuals with preexisting structural lung diseases (eg, bronchiectasis) or genetic and immune dysfunction disorders (eg, alpha-1-antitrypsin deficiency, primary ciliary dyskinesia, and granulocyte-macrophage colony-stimulating factor.)<xref ref-type="bibr" rid="article-24517.r48">[48]</xref><xref ref-type="bibr" rid="article-24517.r49">[49]</xref><xref ref-type="bibr" rid="article-24517.r50">[50]</xref><xref ref-type="bibr" rid="article-24517.r51">[51]</xref>&#x000a0;T-cell depleting therapies have traditionally been implicated in NTM disease, altering T-cell function responses without major lymphopenia.<xref ref-type="bibr" rid="article-24517.r52">[52]</xref>&#x000a0;Human-immunodeficiency virus, which causes a decline in CD4+&#x000a0;cells, is associated with a higher incidence of NTM disease, particularly with lower CD4+ cell counts.<xref ref-type="bibr" rid="article-24517.r53">[53]</xref><xref ref-type="bibr" rid="article-24517.r54">[54]</xref>&#x000a0;B-cell&#x02013;depleting therapies (eg, rituximab) may also be associated with reducing the granuloma response, which contains mycobacteria.<xref ref-type="bibr" rid="article-24517.r55">[55]</xref><xref ref-type="bibr" rid="article-24517.r56">[56]</xref></p>
        <p>In those without predisposing structural lung disease, low body mass index, scoliosis, and thoracic cage abnormalities have been associated with NTM pulmonary disease.<xref ref-type="bibr" rid="article-24517.r57">[57]</xref><xref ref-type="bibr" rid="article-24517.r58">[58]</xref><xref ref-type="bibr" rid="article-24517.r59">[59]</xref>&#x000a0;Gastroesophageal reflux disease has been associated with pulmonary NTM infection, possibly as a result of the survivability of mycobacteria in low-pH environments.<xref ref-type="bibr" rid="article-24517.r60">[60]</xref> Unlike tuberculosis, NTM pulmonary disease is not thought to be transmitted person-to-person or by exposure to droplets from an infected individual.<xref ref-type="bibr" rid="article-24517.r61">[61]</xref>&#x000a0;That all pulmonary NTM become acquired via inhalation of infected aerosolized droplets from the environment or water sources has been accepted. Household water and shower aerosols are known to be colonized with various NTM species, with the most frequently cited being&#x000a0;<italic toggle="yes">M avium, M kansasii, M abscessus</italic>, and <italic toggle="yes">Mycobacterium&#x000a0;lentiflavum</italic>.<xref ref-type="bibr" rid="article-24517.r62">[62]</xref>&#x000a0;Similarly, NTM has been isolated throughout the year in natural and municipal potable water in major cities globally, with species differing according to season.<xref ref-type="bibr" rid="article-24517.r63">[63]</xref>&#x000a0;Once the organisms enter the individual, they usually settle in the lower airways; in some cases, the bacteria incite an inflammatory reaction with an influx of lymphocytes. The resulting release of cytokines and other mediators can lead to an infectious process that presents as pneumonia. With&#x000a0;an insufficient immune response to contain these mycobacteria, the pathogen can disseminate throughout the human host and cause extrapulmonary disease.</p>
      </sec>
      <sec id="article-24517.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The diagnosis of pulmonary NTM infection is based on clinical, radiological, and microbiological criteria. The 2020 ATS/ERS/IDSA/ESCMID guidelines recommend clinical features, radiological opacities, exclusion of differential diagnoses, and positive microbiology from multiple sputum specimens and other respiratory laboratory studies to confirm the diagnosis of pulmonary NTM infection.<xref ref-type="bibr" rid="article-24517.r7">[7]</xref>&#x000a0;As such, a thorough history and physical examination are essential in detecting possible cases of pulmonary NTM infection. Compared to other bacteria, nontuberculous mycobacterium have a slow growth process, resulting in a considerable time to infect the lungs and cause symptomatic disease.<xref ref-type="bibr" rid="article-24517.r64">[64]</xref>&#x000a0;Sometimes, this particular factor and a low clinical suspicion index may result in either misdiagnosis or a delayed diagnosis.</p>
        <p>
<bold>Clinical History</bold>
</p>
        <p>Clinical manifestations may bear similarities with pulmonary tuberculosis infection, including respiratory symptoms such as cough, dyspnea, and increased sputum production.<xref ref-type="bibr" rid="article-24517.r65">[65]</xref>&#x000a0;Patients with pulmonary NTM often have fewer pulmonary cavitations and infiltrates than tuberculosis; however, constitutional symptoms (eg, fevers, night sweats, and weight loss) have been seen to occur more often in pulmonary NTM than in tuberculosis.<xref ref-type="bibr" rid="article-24517.r66">[66]</xref>&#x000a0;Pulmonary NTM disease is associated more with bronchiectasis than tuberculosis, and coinfection with human immunodeficiency virus (HIV) often leads to more disseminated extrapulmonary disease than in tuberculosis, which in tuberculosis patients is more associated with a miliary radiographic appearance.<xref ref-type="bibr" rid="article-24517.r67">[67]</xref>&#x000a0;This is mainly in the case of MAC, where a CD4 count of &#x0003c;50 cells/&#x000b5;L&#x000a0;is at high risk for dissemination in HIV patients.<xref ref-type="bibr" rid="article-24517.r54">[54]</xref>&#x000a0;The duration of symptoms in pulmonary NTM disease may vary from a few days to a few weeks. Chronic pulmonary infection may occur, resulting in structural lung changes such as fibrocavitary disease.<xref ref-type="bibr" rid="article-24517.r68">[68]</xref>&#x000a0;This may lead to differentials such as malignancy, sarcoidosis, vasculitis, and fungal pulmonary disease being considered.<xref ref-type="bibr" rid="article-24517.r69">[69]</xref></p>
        <p>
<bold>Physical Examination Findings</bold>
</p>
        <p>The physical features on examination are often variable, not specific, and can mimic any infectious process of the lungs. Cutaneous lesions may be present in extrapulmonary disease and could represent NTM lymphadenitis. Disseminated MAC may present with hepatosplenomegaly and abdominal pain.<xref ref-type="bibr" rid="article-24517.r64">[64]</xref>&#x000a0;Furthermore, patients with NTM pulmonary infection may have preexisting structural lung disease, including findings of coarse inspiratory crackles on auscultation consistent with bronchiectasis or prolonged expiratory time on spirometry associated with chronic obstructive pulmonary disease.&#x000a0;</p>
      </sec>
      <sec id="article-24517.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>
<bold>Diagnostic Imaging Studies</bold>
</p>
        <p>As with other lung infections, radiological images are crucial for correctly diagnosing the disease. However, unlike other lung diseases,&#x000a0;NTM have characteristic lung presentations. The major radiological patterns of NTM lung infection are fibrocavitary and nodular bronchiectatic patterns (see <bold>Image.</bold> Mycobacterium Avium-Intracellulare Pneumonia).<xref ref-type="bibr" rid="article-24517.r5">[5]</xref>&#x000a0;The fibrocavitary radiological pattern resembles tuberculosis lung infection. It presents with cavities with areas of increased opacity, primarily in the upper lung. On the other hand, the nodular bronchiectasis pattern characteristically shows multilobar bronchiectasis, primarily located in the middle and lower lung fields, with small nodules seen in imaging. This pattern predominantly presents in elderly female nonsmokers without previous lung conditions.<xref ref-type="bibr" rid="article-24517.r70">[70]</xref>&#x000a0;Finally, bronchiectasis is highly prevalent in patients with NTM lung infection. A meta-analysis demonstrated that the prevalence of NTM infection in patients with bronchiectasis was 9.3%.<xref ref-type="bibr" rid="article-24517.r71">[71]</xref>&#x000a0;Clinicians must be aware that NTM lung infection could present with bronchiectasis on radiological images. Disseminated disease manifestations, such as what can occur with MAC infection, can be nonspecific and reveal radiological evidence of hepatosplenomegaly and intestinal and gallbladder wall thickening.<xref ref-type="bibr" rid="article-24517.r72">[72]</xref>&#x000a0;</p>
        <p>
<bold>Diagnostic Laboratory Studies</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Sputum staining</bold>: The isolation of&#x000a0;NTM in human specimens can be challenging. Since NTM are present in the environment, especially in water sources, a positive test in a sputum specimen may be a false-positive due to specimen contamination or represent upper respiratory tract colonization in patients tested for NTM.<xref ref-type="bibr" rid="article-24517.r73">[73]</xref>&#x000a0;Therefore, current international guidelines recommend that 3 early morning sputum specimens be collected on 3 different days to diagnose NTM lung infection accurately.<xref ref-type="bibr" rid="article-24517.r5">[5]</xref>&#x000a0;The methods used for acid-fast bacilli staining require the carbol fuchsin stain (eg, Ziehl-Neelsen or Kinyoun method) and the fluorochrome procedure using auramine O alone or combined with rhodamine B.<xref ref-type="bibr" rid="article-24517.r74">[74]</xref><xref ref-type="bibr" rid="article-24517.r75">[75]</xref>&#x000a0;However, these staining methods cannot differentiate between tuberculosis and NTM alone, and further tests are required to identify the pathogen.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Nuclei-acid amplification</bold>: Nuclei-acid amplification (NAA) is the most accurate test for identifying mycobacterial strains. Commercial polymerase chain reaction assays have shown a sensitivity of up to 97.7% in acid-fast bacilli smear-positive specimens, with a specificity of up to 97.7%, by targeting conserved sequences such as insertion sequence 6110 and the mpb64 gene.<xref ref-type="bibr" rid="article-24517.r76">[76]</xref><xref ref-type="bibr" rid="article-24517.r77">[77]</xref><xref ref-type="bibr" rid="article-24517.r78">[78]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Sputum culture and sensitivity</bold>: Culture remains the test of choice for NTM laboratory confirmation. Solid and liquid media are used for the culture. Solid media includes egg-based media, such as the L&#x000f6;wenstein-Jensen medium, or agar-based media (eg, middlebrook 7H10 and 7H11 media).<xref ref-type="bibr" rid="article-24517.r79">[79]</xref>&#x000a0;Solid media allows the visualization of morphology, growth rate, and species characterization. The liquid media system is more sensitive but is more prone to contamination by other microorganisms and bacteria overgrowth. Both culture methods are limited by the growth time of the organisms, the risk posed by potential contaminants, and the effect of prior empirical antimicrobials on mycobacterial growth following collection.<xref ref-type="bibr" rid="article-24517.r80">[80]</xref><xref ref-type="bibr" rid="article-24517.r81">[81]</xref>&#x000a0;A timely diagnosis is important as delays between recognizing the causative organism of NTM disease, performing susceptibility testing, and initiating treatment can result in delays ranging from 1.3 to 20.8 months.<xref ref-type="bibr" rid="article-24517.r82">[82]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Nontuberculous Mycobacterium Identification </bold>
</p>
        <p>The treatment of NTM infection is specific and different for every NTM species. Correctly identifying the species is the main factor of successful treatment. The most accurate NTM identification method is via gene sequence. Sequencing the 16S rRNA gene allows for the correct identification and discrimination between species, and whole genome sequencing has been used in public health investigations of mycobacterium outbreaks.<xref ref-type="bibr" rid="article-24517.r83">[83]</xref><xref ref-type="bibr" rid="article-24517.r84">[84]</xref>&#x000a0;However, species-level identification may need several gene sequences and more complex methods. Only specialized laboratories that identify species levels using different gene sequences can perform this test. The matrix-associated laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) method has increasingly been employed for identifying NTM and is highly reproducible for this use.<xref ref-type="bibr" rid="article-24517.r85">[85]</xref>&#x000a0;This method identifies target bacteria by comparing mass spectral pattern molecules specific to NTM.</p>
        <p>
<bold>Drug Susceptibility</bold>
</p>
        <p>When NTM are cultured, drug susceptibility tests are always conducted to assist clinicians with choosing drug regimens due to the variable resistance patterns of different NTM organisms. However, there are difficulties with the drug susceptibility test because each species of NTM may behave differently&#x000a0;in vitro&#x000a0;than&#x000a0;in vivo<italic toggle="yes">, </italic>and there is limited data regarding clinical outcomes based on in vitro susceptibility testing.<xref ref-type="bibr" rid="article-24517.r5">[5]</xref><xref ref-type="bibr" rid="article-24517.r86">[86]</xref> One exception is using macrolides in MAC, where there is a correlation between in vitro susceptibility and in vivo responses. Macrolide testing in vitro for clarithromycin is also often extrapolated to azithromycin usage in clinical practice due to safer differences in drug-drug interactions, improved dosing regimens, and similar clinical outcomes despite similarities in cross-resistance.<xref ref-type="bibr" rid="article-24517.r87">[87]</xref>&#x000a0;NTM species may have variable resistance to certain drugs, and thus, antimicrobial susceptibility tests should be adapted to each organism once cultured. For example, <italic toggle="yes">M kansasii</italic> may show resistance to rifamycins, and alternative agents (eg, tetracyclines, fluoroquinolones, and carbapenems) may need to be tested.<xref ref-type="bibr" rid="article-24517.r5">[5]</xref>&#x000a0;<italic toggle="yes">M abscessus</italic> has been shown to have inducible macrolide resistance, which can often mean prolonged therapy with intravenous amikacin, imipenem, or cefoxitin if these drugs show NTM susceptibility.<xref ref-type="bibr" rid="article-24517.r88">[88]</xref><xref ref-type="bibr" rid="article-24517.r89">[89]</xref></p>
      </sec>
      <sec id="article-24517.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The treatment of NTM requires a holistic and patient-centered approach based on quality-of-life and patient benefits instead of expecting mycobacterial eradication. Pulmonary NTM infection differs from a TB lung infection in that it does not require immediate initiation of treatment upon diagnosis but should be expected within a reasonable timeframe to limit disease progression.<xref ref-type="bibr" rid="article-24517.r90">[90]</xref>&#x000a0;The treatment of NTM lung infection includes an interprofessional approach and a discussion of risks and benefits. The therapy should remain in place for a minimum of 12 months from culture conversion.<xref ref-type="bibr" rid="article-24517.r5">[5]</xref><xref ref-type="bibr" rid="article-24517.r90">[90]</xref>&#x000a0;Culture conversion is where 3 consecutive monthly sputum cultures are negative for NTM after initial positive smears.<xref ref-type="bibr" rid="article-24517.r91">[91]</xref>&#x000a0;Based on data in cystic fibrosis patients, sputum cultures should also be collected every 4 to 8 weeks until 12 months from culture conversion.<xref ref-type="bibr" rid="article-24517.r92">[92]</xref>&#x000a0;For patients unable to expectorate, meeting the definition of culture conversion may be difficult and bronchoscopy and imaging may be required to confirm conversion.<xref ref-type="bibr" rid="article-24517.r6">[6]</xref>&#x000a0;During the treatment phase, pulmonary NTM patients require close monitoring for drug adverse effects and medication adherence, as most patients will require a median of 5 with a range of 1 to 10 antibiotics to achieve culture conversion.<xref ref-type="bibr" rid="article-24517.r93">[93]</xref>&#x000a0;This is important as the cost for treatment over a lifetime for pulmonary NTM can range anywhere from $398 to $70000, based on 2009 data.</p>
        <p>
<bold><italic toggle="yes">Mycobacterium avium-intracellular</italic>&#x000a0;complex Lung Disease Treatment</bold>
</p>
        <p>MAC lung disease treatment depends on clinical presentation, including nodular or bronchiectasis disease, cavitary diseases, and advanced (ie, severe) or previously treated disease. Guideline-based treatment recommends a combination of a macrolide, ethambutol, and a rifamycin 3 times weekly for at least 12 months after culture conversion, with an option to include aminoglycosides for severe and refractory cases. Second-line agents may be required for macrolide-resistant strains.<xref ref-type="bibr" rid="article-24517.r90">[90]</xref>&#x000a0;Treatment 3 times per week is recommended due to its tolerability compared to daily dosing and reduced pill costs. The following treatment dosing scenarios for MAC lung disease are based on the 2020 ATS/ERS/IDSA/ESCMID guidelines.<xref ref-type="bibr" rid="article-24517.r5">[5]</xref></p>
        <p>
<bold>Bronchiectasis or Cavitary Disease Treatment</bold>
</p>
        <p>The first regimen for the treatment of bronchiectasis disease includes clarithromycin 1000 mg 3 times per week or azithromycin 500&#x000a0;to 600 mg 3 times per week together with a rifamycin 600 mg 3 times per week and ethambutol 25 mg/kg 3 times per week. The primary treatment regimen for cavitary disease is clarithromycin 500&#x000a0;to 1000 mg daily or azithromycin 250&#x000a0;to 300 mg daily with ethambutol 15 mg/kg daily and rifampin 450 to 600 mg daily. Furthermore, intramuscular streptomycin or intravenous amikacin 10 mg to 15 mg/kg 3 times weekly can be an added therapy.<xref ref-type="bibr" rid="article-24517.r87">[87]</xref></p>
        <p>
<bold>Advanced Disease Treatment</bold>
</p>
        <p>The treatment of advanced (severe) or previously treated disease includes clarithromycin 500&#x000a0;to 1000 mg daily or azithromycin 250 to 300 mg daily together with rifabutin 150&#x000a0;to 300 mg or rifampin 450&#x000a0;to 600 mg once daily, ethambutol 15 mg/kg daily, and streptomycin or amikacin 10 to 15 mg/kg intramuscular or intravenous 3 times/week with a maximum dose of 500 mg for patients older than 50 years for the first 2&#x000a0;to 3 months. Adding moxifloxacin 400 mg&#x000a0;orally once daily to the previous combination regimen may improve outcomes in refractory diseases or treatment failure.</p>
        <p>
<bold>Refractory Disease Treatment</bold>
</p>
        <p>Refractory pulmonary infection is a failure to achieve negative cultures for more than 6 months. The benefit of additional drugs is controversial as there is a lack of large-scale studies to guide evidence in this scenario.<xref ref-type="bibr" rid="article-24517.r94">[94]</xref>&#x000a0;The guideline-directed regimen of treatment is the administration of amikacin liposome inhalation suspension once daily at a dose of 590 mg/8.4 milliliters (one vial) with&#x000a0;a specialized&#x000a0;nebulizer system only, along with an optimized multi-drug background regimen, still typically consisting of a macrolide, rifamycin, and ethambutol.<xref ref-type="bibr" rid="article-24517.r91">[91]</xref><xref ref-type="bibr" rid="article-24517.r90">[90]</xref><xref ref-type="bibr" rid="article-24517.r95">[95]</xref></p>
        <p>
<bold>Duration of Therapy </bold>
</p>
        <p>Nontuberculous mycobacterial antimicrobial therapy aims to achieve culture conversion. Those achieving 3 consecutive monthly negative sputum cultures 12 months after the last positive cultures for 6 months should continue for an additional 12 months.<xref ref-type="bibr" rid="article-24517.r91">[91]</xref>&#x000a0;The benefit of extended therapy in those not achieving 3 consecutive monthly negative sputum cultures by 6 months is not entirely established. However, it has been observed that patients treated for longer than 12 months achieve culture conversion within a shorter period, &#x0003c;12 months, associated with reduced mortality in pulmonary NTM infection.<xref ref-type="bibr" rid="article-24517.r82">[82]</xref></p>
        <p>
<bold><italic toggle="yes">Mycobacterium Kansasii</italic>&#x000a0;Lung Disease Treatment</bold>
</p>
        <p><italic toggle="yes">M kansasii</italic>&#x000a0;lung disease remains a relatively treatable pathogen among NTM lung diseases despite being the second most common cause of pulmonary NTM in the US.<xref ref-type="bibr" rid="article-24517.r5">[5]</xref>&#x000a0;With the advent of rifamycin-based treatment regimens, sputum conversion remains high. Guideline-directed therapy is similar to tuberculosis treatment, with a high curative rate. The recommended primary regimens for adults are isoniazid 300 mg daily, pyridoxine 50 mg daily, rifampin 600 mg daily, and ethambutol 15 mg/kg per day for 12 months of culture-negative sputum. Disseminated disease is treated in the same manner as pulmonary disease. Susceptibility testing should be used to guide treatment in rifamycin-resistant cases, which may include macrolides, sulfamethoxazole, and streptomycin. It has been demonstrated that adding an aminoglycoside such as&#x000a0;streptomycin&#x000a0;during the first 2&#x000a0;to 3 months to the 3-drug regimen has a high rate of culture conversion with a low relapse rate.<xref ref-type="bibr" rid="article-24517.r96">[96]</xref></p>
        <p>
<italic toggle="yes">
<bold>Mycobacterium</bold>
</italic>
<italic toggle="yes">&#x000a0;<bold>Abscessus</bold></italic>
<bold>&#x000a0;Complex&#x000a0;Lung Disease Treatment</bold>
</p>
        <p>MAC&#x000a0;lung infection treatment remains complicated because of the high treatment failure rate due to resistance against standard treatment for mycobacterial species.<xref ref-type="bibr" rid="article-24517.r97">[97]</xref>&#x000a0;Therefore, more clinical trials are needed to establish a successful treatment that eradicates and cures the disease. The primary regimen generally consists of a macrolide with 2 parenteral agents for an extended period in isolates without macrolide resistance. Also, the treatment is divided between the intensive phase, which uses imipenem 1000 mg intravenously (IV) every 12 hrs or cefoxitin IV 8&#x000a0;to 12 g daily, divided into 2&#x000a0;or 3 doses, azithromycin 250&#x000a0;to 500 mg orally once daily along with amikacin IV 15 mg/kg once daily with adjustable doses until obtaining peak serum concentration of 20&#x000a0;to 30 &#x000b5;g/mL. Generally, another oral agent, which includes clofazimine or linezolid, is used. This proposed treatment should last 2&#x000a0;or 3 months, depending on the severity of infection, clinical response, tolerability, and toxicity.</p>
        <p>Finally, the continuation phase uses azithromycin 250 to 500 mg once daily, clofazimine 100 to 200 mg once daily, or linezolid 600 mg to 1200 mg once daily with inhaled liposomal amikacin 590 mg 3 times weekly for a minimum of 12 months from culture conversion.<xref ref-type="bibr" rid="article-24517.r98">[98]</xref><xref ref-type="bibr" rid="article-24517.r99">[99]</xref><xref ref-type="bibr" rid="article-24517.r100">[100]</xref><xref ref-type="bibr" rid="article-24517.r101">[101]</xref>&#x000a0;Macrolide-resistant isolates are more difficult to treat and often require 2 to 3 parental antimicrobials in addition to 2 to 3 oral agents daily (eg, clofazimine and linezolid) in the induction phase, followed by 3 oral agents and inhaled liposomal amikacin 3 times weekly for a minimum of 12 months following culture conversion based on susceptibility testing.<xref ref-type="bibr" rid="article-24517.r90">[90]</xref></p>
        <p>
<bold>Pharmacologic Adverse Effects</bold>
</p>
        <p>Of great importance to patient care is the pre-treatment counseling of potential medication adverse effects, reactions, and drug interactions. Clinicians and pharmacists must never forget that patients should be educated and counseled as much as possible regarding the risks and benefits of any novel treatment, particularly in pulmonary NTM disease, where antimicrobials are not without adverse effects. In the case of treatment with NTM, the most used medications are macrolides and other anti-tuberculosis medications like rifampin.</p>
        <p>In the case of macrolides like azithromycin or erythromycin, the most common adverse effects are gastrointestinal symptoms, including nausea, vomiting, diarrhea, abdominal pain, and cholestatic hepatitis.<xref ref-type="bibr" rid="article-24517.r102">[102]</xref>&#x000a0;Macrolides can also be associated with QT prolongation, leading to cardiac arrhythmias.<xref ref-type="bibr" rid="article-24517.r103">[103]</xref>&#x000a0;Having a baseline EKG when using this medication is essential. Otoxicity and transient reversible tinnitus or deafness have occurred with&#x000a0;over 4 g daily of erythromycin IV in renal allograft patients.<xref ref-type="bibr" rid="article-24517.r104">[104]</xref>&#x000a0;This effect is thought to be due to drug accumulation and has been seen with azithromycin and clarithromycin.<xref ref-type="bibr" rid="article-24517.r105">[105]</xref></p>
        <p>Rifampin is a potentially hepatotoxic cause of drug-induced liver injury, particularly in those with predisposing genotypes.<xref ref-type="bibr" rid="article-24517.r106">[106]</xref><xref ref-type="bibr" rid="article-24517.r107">[107]</xref>&#x000a0;It requires caution in patients with preexisting liver impairment or excessive use of alcohol. If elevated bilirubin or a substantive increase in liver-associated enzymes occurs, discontinue rifampin therapy. A visual adverse effect of rifampin is red-orange discoloration of urine, feces, and saliva.<xref ref-type="bibr" rid="article-24517.r108">[108]</xref>&#x000a0;It can stain contact lenses permanently. In instances of rifampin overdosage of &#x0003e;14 grams per day, cardiopulmonary arrest may occur.<xref ref-type="bibr" rid="article-24517.r109">[109]</xref>&#x000a0;There are also reports of thrombocytopenia and vasculitis, thought to be secondary to the formation of autoantibodies.<xref ref-type="bibr" rid="article-24517.r110">[110]</xref><xref ref-type="bibr" rid="article-24517.r111">[111]</xref>&#x000a0;Rifampin is also a potent inducer of cytochrome p450 liver enzymes and can interact with other NTM drugs, including ethambutol and clofazimine.<xref ref-type="bibr" rid="article-24517.r112">[112]</xref></p>
        <p>
<bold>Surgical Therapy</bold>
</p>
        <p>Nontuberculosis and mycobacterial pulmonary infections can be challenging to manage with antibiotic therapy. By targeting areas of the lung where antimicrobials have poor perfusion due to parenchymal injury, adjuvant surgical therapy may remove the most severely destroyed lung and promote treatment success. Surgical therapy is recommended in the settings of treatment-refractory disease and symptom control.<xref ref-type="bibr" rid="article-24517.r113">[113]</xref>&#x000a0;Surgery may also be the best choice for disease control in the case of massive hemoptysis. Some case series and reviews have reported successful treatment, with 80% to 100% sputum conversion in patients after adjuvant surgical reception<xref ref-type="bibr" rid="article-24517.r114">[114]</xref><xref ref-type="bibr" rid="article-24517.r115">[115]</xref>. Surgery requires a comprehensive preoperative evaluation since recent research has shown that postoperative complications have a morbidity of 7%&#x000a0;to 25% and a mortality rate of 0%&#x000a0;to 3%.<xref ref-type="bibr" rid="article-24517.r113">[113]</xref></p>
      </sec>
      <sec id="article-24517.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The clinical manifestation of NTM could mimic other lung infections, such as&#x000a0;<italic toggle="yes">M tuberculosis</italic>, atypical bacterial infections, and chronic lung diseases.<xref ref-type="bibr" rid="article-24517.r66">[66]</xref>&#x000a0;Though NTM, including MAC, <italic toggle="yes">M abscessus</italic>, and <italic toggle="yes">M kansasii</italic>,&#x000a0;are frequently associated with pulmonary disease, others, such as <italic toggle="yes">Mycobacterium ulcerans</italic> and <italic toggle="yes">Mycobacterium marinum</italic>, are less associated.<xref ref-type="bibr" rid="article-24517.r116">[116]</xref>&#x000a0;Clinicians should approach the differential diagnosis of pulmonary pathologies based on the patient's background risk factors, the disease's clinical manifestations, and&#x000a0;any&#x000a0;radiological characteristics. Among the differentials, infections, neoplasias, and connective tissue diseases most commonly share similarities to NTM lung infections.&#x000a0;<italic toggle="yes">Klebsiella pneumoniae</italic>,<italic toggle="yes"> Staphylococcus aureus</italic>, and<italic toggle="yes"> Burkholderia pseudomallei</italic>&#x000a0;are relevant entities to include in the differential.<xref ref-type="bibr" rid="article-24517.r117">[117]</xref><xref ref-type="bibr" rid="article-24517.r118">[118]</xref><xref ref-type="bibr" rid="article-24517.r69">[69]</xref>&#x000a0;</p>
        <p>Other&#x000a0;pertinent infectious differentials include&#x000a0;fungal lung infections&#x000a0;such as&#x000a0;<italic toggle="yes">Aspergillus</italic>,&#x000a0;<italic toggle="yes">Cryptococcus</italic>, <italic toggle="yes">Mucor</italic>,&#x000a0;<italic toggle="yes">Histoplasma</italic>, and&#x000a0;<italic toggle="yes">Coccidiodes&#x000a0;</italic>species, particularly<italic toggle="yes">&#x000a0;</italic>if<italic toggle="yes">&#x000a0;</italic>cavitary lung disease is present.<xref ref-type="bibr" rid="article-24517.r69">[69]</xref><xref ref-type="bibr" rid="article-24517.r119">[119]</xref><xref ref-type="bibr" rid="article-24517.r120">[120]</xref><xref ref-type="bibr" rid="article-24517.r121">[121]</xref><xref ref-type="bibr" rid="article-24517.r122">[122]</xref>&#x000a0;Given their similar radiological appearances, small-cell and non-small-cell lung cancers are important to consider among neoplasias. Moreover, connective tissue disorders, including rheumatoid arthritis, lung diseases, granulomatosis with polyangiitis, or eosinophilic granulomatosis with polyangiitis, represent an essential part of the differential.<xref ref-type="bibr" rid="article-24517.r123">[123]</xref>&#x000a0;Overall, any entity that presents with respiratory manifestations, and either cavitary or bronchiectasis radiological lung pictures on images, is part of the differential diagnostic, and these conditions need to be ruled out by the treating clinician.</p>
      </sec>
      <sec id="article-24517.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis of NTM lung infection is guarded, particularly if left untreated. A South Korean population study analyzed 183267 NTM infections and found the 6-, 10- and 14-year survival probabilities were 86.3%, 80.8%, and 77.1%, respectively, despite treatment.<xref ref-type="bibr" rid="article-24517.r124">[124]</xref>&#x000a0;Similar findings have also been found in Croatia, where a study of 436 pulmonary NTM patients observed a 5-year survival rate of 60% compared to 70% in patients without pulmonary NTM.</p>
        <p>Patients with a fragile immune system are more prone to worse outcomes when compared with immunocompetent patients. Furthermore, pulmonary NTM patients with comorbidities have been observed to have survival expectancy following diagnosis reduced to as low as 8.6 years compared to those without comorbidities.<xref ref-type="bibr" rid="article-24517.r125">[125]</xref>&#x000a0;The method of diagnosis has also been shown to correlate with disease progression, with patients who have NTM pulmonary disease diagnosed through means other than sputum having a lower risk of disease progression over 5 years compared to those diagnosed by sputum culture.<xref ref-type="bibr" rid="article-24517.r126">[126]</xref>&#x000a0;The prognosis also depends on the type of NTM lung infection. Studies have shown that patients with MAC lung infections have a better prognosis when compared to patients with other NTM infections.<xref ref-type="bibr" rid="article-24517.r127">[127]</xref>&#x000a0;Conversely, the mortality rate of patients with&#x000a0;pulmonary&#x000a0;infections with&#x000a0;<italic toggle="yes">M abscessus&#x000a0;</italic>is greater when compared with patients with other NTM lung infections.<xref ref-type="bibr" rid="article-24517.r128">[128]</xref>&#x000a0;Other prognostic risk factors for mortality identified on multivariable analyses from 15-year cohort studies include older age &#x02265;65 years, male sex, a body mass index &#x0003c;18.5 kg per square meter, underlying chronic cardiac and liver diseases, chronic pulmonary aspergillosis and cavitary lung disease at presentation.<xref ref-type="bibr" rid="article-24517.r129">[129]</xref></p>
      </sec>
      <sec id="article-24517.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Pulmonary NTM infections can affect both immunocompetent and immunocompromised hosts in several ways. Affected patients can be asymptomatic, minimally symptomatic, or have serious complications such as pulmonary cavitations or constitutional disease.<xref ref-type="bibr" rid="article-24517.r66">[66]</xref><xref ref-type="bibr" rid="article-24517.r130">[130]</xref>&#x000a0;In a systemic review of 206 pulmonary NTM infections, 29% had pleural disease alone, 43% developed pneumothorax, 16% empyema, and 16.5% broncho-pleural fistulas. From this cohort, 53% required pleural effusion drainage, and 26% required surgical intervention.<xref ref-type="bibr" rid="article-24517.r131">[131]</xref>&#x000a0;The cohort experienced a mortality rate of 24%, with 53% requiring pleural effusion drainage and 26% requiring surgical intervention. Necrotizing granulomas and chronic interstitial pneumonia and organization may occur.<xref ref-type="bibr" rid="article-24517.r132">[132]</xref>&#x000a0;In patients with NTM and chronic thromboembolic pulmonary disease, those with NTM have been observed to be more thrombus-obstructed than those without NTM.<xref ref-type="bibr" rid="article-24517.r133">[133]</xref>&#x000a0;</p>
        <p>Among lung transplant recipients, survival is similar among NTM-infected and uninfected patients, but there is a trend toward having NTM infection and having bronchiolitis obliterans.<xref ref-type="bibr" rid="article-24517.r134">[134]</xref>&#x000a0;Treatment among cystic fibrosis patients may also be challenging as host physiology may mean altered drug absorption and clearance of drugs, resulting in persisting NTM disease if drug monitoring is not available.<xref ref-type="bibr" rid="article-24517.r135">[135]</xref>&#x000a0;</p>
        <p>Extrapulmonary complications may also develop following initial pulmonary NTM infection, particularly in immunocompromised patients. Osteoarticular diseases such as tenosynovitis, arthritis, and vertebral osteomyelitis can occur following initial pleural infection with NTM.<xref ref-type="bibr" rid="article-24517.r136">[136]</xref>&#x000a0;The most frequently cited NTM associated with osteoarticular infection includes&#x000a0;<italic toggle="yes">M kansas</italic>ii and&#x000a0;<italic toggle="yes">M marinum</italic>, though other NTM species such as<italic toggle="yes">&#x000a0;</italic>MAC,&#x000a0;<italic toggle="yes">M chelonae, M szulgai</italic>, and&#x000a0;<italic toggle="yes">M abscessus</italic>&#x000a0;have also been implicated.<xref ref-type="bibr" rid="article-24517.r137">[137]</xref>&#x000a0;In severe immunosuppression, disseminated MAC has been associated with impaired erythropoiesis and elevated liver alkaline phosphatase.<xref ref-type="bibr" rid="article-24517.r138">[138]</xref><xref ref-type="bibr" rid="article-24517.r139">[139]</xref>&#x000a0;This may be linked to the clinical manifestations in disseminated MAC of hepatosplenomegaly and osteoarticular disease.<xref ref-type="bibr" rid="article-24517.r136">[136]</xref><xref ref-type="bibr" rid="article-24517.r137">[137]</xref></p>
      </sec>
      <sec id="article-24517.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Prevention of NTM is a rather challenging task due to its ubiquitous presence in the environment, limiting the precautions that can be put in place to limit exposure to susceptible individuals. Compounding this challenge is the difficulty of assessing which patients are susceptible to NTM infection. A notable example is that hot showers, indoor swimming pools, and plumbing may be associated with viable NTM, but not all individuals who take hot showers have NTM infection.<xref ref-type="bibr" rid="article-24517.r41">[41]</xref><xref ref-type="bibr" rid="article-24517.r42">[42]</xref><xref ref-type="bibr" rid="article-24517.r44">[44]</xref>&#x000a0;Whether educating the patient on avoiding hot showers will decrease the chances of infection is unclear. There is limited data that supports evidence-based environmental strategies to limit the transmission of NTM. Therefore, discussing general precautions with patients at risk for pulmonary NTM infection may be prudent.</p>
        <p>Concerning management, the patient should be advised regarding the estimated duration of any proposed treatment, as this could be very lengthy. An organized and structured care plan agreed to by the patient and their family that details dosing regimens, follow-up appointments, and contact details of healthcare clinicians can optimize adherence and patient engagement. The plan may also include adverse effects and a timeframe for treatment completeness. Patients must be aware of potential complications from any disease progression. They also should be counseled on the expected time for sputum culture conversion and the anticipated duration of antimicrobial treatment for more than 12 months following culture conversion to achieve disease-free status. Building patient rapport and healthy relationships with the patient to obtain the best results is essential.</p>
      </sec>
      <sec id="article-24517.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The diagnosis and treatment of NTM are complex and best done with an interprofessional, multidisciplinary team with a holistic approach to management.&#x000a0;The pharmacist should educate the patient on the importance of drug adherence and counsel on potential adverse effects while checking the medication record and verifying dosing and drug interactions. An infectious disease pharmacist can also review antibiogram data with the clinician to optimize antimicrobial effectiveness, limit adverse effects, and determine antibiotic resistance. Infectious disease or respiratory nurses are essential for patient care, infection control measures while tuberculosis is being excluded, medication administration, verifying adherence, monitoring for adverse events, offering patients counsel, and reporting any concerns to the treating physicians.</p>
        <p>Daily observed therapy may sometimes be necessary to maintain medication adherence until treatment completion.<xref ref-type="bibr" rid="article-24517.r140">[140]</xref>&#x000a0;The patient should be urged to cease smoking to limit symptom burden and any progression of disease. A holistic approach considers all these factors in partnership with the patient to determine the buy-in and optimal pathway to complete the long-anticipated treatment duration for pulmonary NTM.<xref ref-type="bibr" rid="article-24517.r141">[141]</xref>&#x000a0;Therefore, a patient-centered approach can improve clinical outcomes, patient safety, and multidisciplinary team performance.</p>
      </sec>
      <sec id="article-24517.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=24517&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=24517">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/infectious-disease/lung-nontuberculous-mycobacterial-infections/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=24517">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/24517/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=24517">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-24517.s15">
        <fig id="article-24517.image.f1" position="float" orientation="portrait">
          <caption>
            <p><italic toggle="yes">Mycobacterium Kansasii</italic> Contributed by S Bhimji, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="My__kansasii" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-24517.s16">
        <fig id="article-24517.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Chest X-ray of Mycobacterium Avium-Intracellulare Pneumonia. Contributed by&#x000a0;S Bhimji, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="MAI__pneumonia" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-24517.s17">
        <fig id="article-24517.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Chest CT of <italic toggle="yes">Mycobacterium Abscessus</italic> Image courtesy S Bhimji, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="My__abscessus" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-24517.s18">
        <title>References</title>
        <ref id="article-24517.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pinner</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>IV. Atypical Acid Fast Organisms: II. Some Observations on Filtration Experiments.</article-title>
            <source>J Bacteriol</source>
            <year>1933</year>
            <month>Jun</month>
            <volume>25</volume>
            <issue>6</issue>
            <fpage>576</fpage>
            <page-range>576-9</page-range>
            <pub-id pub-id-type="pmid">16559638</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kendall</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Winthrop</surname>
                <given-names>KL</given-names>
              </name>
            </person-group>
            <article-title>Update on the epidemiology of pulmonary nontuberculous mycobacterial infections.</article-title>
            <source>Semin Respir Crit Care Med</source>
            <year>2013</year>
            <month>Feb</month>
            <volume>34</volume>
            <issue>1</issue>
            <fpage>87</fpage>
            <page-range>87-94</page-range>
            <pub-id pub-id-type="pmid">23460008</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Prevots</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Marras</surname>
                <given-names>TK</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review.</article-title>
            <source>Clin Chest Med</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>36</volume>
            <issue>1</issue>
            <fpage>13</fpage>
            <page-range>13-34</page-range>
            <pub-id pub-id-type="pmid">25676516</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kee</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Suh</surname>
                <given-names>SP</given-names>
              </name>
            </person-group>
            <article-title>Increasing Burden of Nontuberculous Mycobacteria in Korea.</article-title>
            <source>J Korean Med Sci</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>32</volume>
            <issue>8</issue>
            <fpage>1215</fpage>
            <page-range>1215-1216</page-range>
            <pub-id pub-id-type="pmid">28665053</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Griffith</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Aksamit</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Brown-Elliott</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Catanzaro</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Daley</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gordin</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Holland</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Horsburgh</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Huitt</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Iademarco</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Iseman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Olivier</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ruoss</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>von Reyn</surname>
                <given-names>CF</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Winthrop</surname>
                <given-names>K</given-names>
              </name>
              <collab>ATS Mycobacterial Diseases Subcommittee</collab>
              <collab>American Thoracic Society</collab>
              <collab>Infectious Disease Society of America</collab>
            </person-group>
            <article-title>An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.</article-title>
            <source>Am J Respir Crit Care Med</source>
            <year>2007</year>
            <month>Feb</month>
            <day>15</day>
            <volume>175</volume>
            <issue>4</issue>
            <fpage>367</fpage>
            <page-range>367-416</page-range>
            <pub-id pub-id-type="pmid">17277290</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haworth</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Banks</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Capstick</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Fisher</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Gorsuch</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Laurenson</surname>
                <given-names>IF</given-names>
              </name>
              <name>
                <surname>Leitch</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Loebinger</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Milburn</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Nightingale</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ormerod</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Shingadia</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Whitehead</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Floto</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD).</article-title>
            <source>Thorax</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>72</volume>
            <issue>Suppl 2</issue>
            <fpage>ii1</fpage>
            <page-range>ii1-ii64</page-range>
            <pub-id pub-id-type="pmid">29054853</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Daley</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Iaccarino</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Lange</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cambau</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Andrejak</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>B&#x000f6;ttger</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Brozek</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Griffith</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Guglielmetti</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Huitt</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Knight</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Leitman</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Marras</surname>
                <given-names>TK</given-names>
              </name>
              <name>
                <surname>Olivier</surname>
                <given-names>KN</given-names>
              </name>
              <name>
                <surname>Santin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Stout</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Tortoli</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>van Ingen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wagner</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Winthrop</surname>
                <given-names>KL</given-names>
              </name>
            </person-group>
            <article-title>Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline.</article-title>
            <source>Eur Respir J</source>
            <year>2020</year>
            <month>Jul</month>
            <volume>56</volume>
            <issue>1</issue>
            <pub-id pub-id-type="pmid">32636299</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cambau</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Drancourt</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Steps towards the discovery of Mycobacterium tuberculosis by Robert Koch, 1882.</article-title>
            <source>Clin Microbiol Infect</source>
            <year>2014</year>
            <month>Mar</month>
            <volume>20</volume>
            <issue>3</issue>
            <fpage>196</fpage>
            <page-range>196-201</page-range>
            <pub-id pub-id-type="pmid">24450600</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>RUNYON</surname>
                <given-names>EH</given-names>
              </name>
            </person-group>
            <article-title>Anonymous mycobacteria in pulmonary disease.</article-title>
            <source>Med Clin North Am</source>
            <year>1959</year>
            <month>Jan</month>
            <volume>43</volume>
            <issue>1</issue>
            <fpage>273</fpage>
            <page-range>273-90</page-range>
            <pub-id pub-id-type="pmid">13612432</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grange</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Yates</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Boughton</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>The avian tubercle bacillus and its relatives.</article-title>
            <source>J Appl Bacteriol</source>
            <year>1990</year>
            <month>May</month>
            <volume>68</volume>
            <issue>5</issue>
            <fpage>411</fpage>
            <page-range>411-31</page-range>
            <pub-id pub-id-type="pmid">2196253</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wolinsky</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Nontuberculous mycobacteria and associated diseases.</article-title>
            <source>Am Rev Respir Dis</source>
            <year>1979</year>
            <month>Jan</month>
            <volume>119</volume>
            <issue>1</issue>
            <fpage>107</fpage>
            <page-range>107-59</page-range>
            <pub-id pub-id-type="pmid">369415</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Runyon</surname>
                <given-names>EH</given-names>
              </name>
            </person-group>
            <article-title>Micobacterium intracellulare.</article-title>
            <source>Am Rev Respir Dis</source>
            <year>1967</year>
            <month>May</month>
            <volume>95</volume>
            <issue>5</issue>
            <fpage>861</fpage>
            <page-range>861-5</page-range>
            <pub-id pub-id-type="pmid">6023519</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tortoli</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Microbiological features and clinical relevance of new species of the genus Mycobacterium.</article-title>
            <source>Clin Microbiol Rev</source>
            <year>2014</year>
            <month>Oct</month>
            <volume>27</volume>
            <issue>4</issue>
            <fpage>727</fpage>
            <page-range>727-52</page-range>
            <pub-id pub-id-type="pmid">25278573</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cook</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Berney</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gebhard</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Heinemann</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cox</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Danilchanka</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Niederweis</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Physiology of mycobacteria.</article-title>
            <source>Adv Microb Physiol</source>
            <year>2009</year>
            <volume>55</volume>
            <fpage>81</fpage>
            <page-range>81-182, 318-9</page-range>
            <pub-id pub-id-type="pmid">19573696</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gangadharam</surname>
                <given-names>PR</given-names>
              </name>
            </person-group>
            <article-title>Microbiology of nontuberculosis mycobacteria.</article-title>
            <source>Semin Respir Infect</source>
            <year>1996</year>
            <month>Dec</month>
            <volume>11</volume>
            <issue>4</issue>
            <fpage>231</fpage>
            <page-range>231-43</page-range>
            <pub-id pub-id-type="pmid">8976577</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bittner</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Preheim</surname>
                <given-names>LC</given-names>
              </name>
            </person-group>
            <article-title>Other Slow-Growing Nontuberculous Mycobacteria.</article-title>
            <source>Microbiol Spectr</source>
            <year>2016</year>
            <month>Nov</month>
            <volume>4</volume>
            <issue>6</issue>
            <pub-id pub-id-type="pmid">27837745</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>NH</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Choe</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>HB</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>WB</given-names>
              </name>
              <name>
                <surname>Oh</surname>
                <given-names>MD</given-names>
              </name>
            </person-group>
            <article-title>Differentiating rapid- and slow-growing mycobacteria by difference in time to growth detection in liquid media.</article-title>
            <source>Diagn Microbiol Infect Dis</source>
            <year>2013</year>
            <month>Jan</month>
            <volume>75</volume>
            <issue>1</issue>
            <fpage>73</fpage>
            <page-range>73-6</page-range>
            <pub-id pub-id-type="pmid">23114094</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Springer</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Stockman</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Teschner</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>B&#x000f6;ttger</surname>
                <given-names>EC</given-names>
              </name>
            </person-group>
            <article-title>Two-laboratory collaborative study on identification of mycobacteria: molecular versus phenotypic methods.</article-title>
            <source>J Clin Microbiol</source>
            <year>1996</year>
            <month>Feb</month>
            <volume>34</volume>
            <issue>2</issue>
            <fpage>296</fpage>
            <page-range>296-303</page-range>
            <pub-id pub-id-type="pmid">8789004</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Asaoka</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hagiwara</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Etori</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Higa</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ikeda</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sekine</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kitamura</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Baba</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Komatsu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ogura</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Identification and Characteristics of Co-isolation of Multiple Nontuberculous Mycobacteria.</article-title>
            <source>Intern Med</source>
            <year>2021</year>
            <month>Oct</month>
            <day>15</day>
            <volume>60</volume>
            <issue>20</issue>
            <fpage>3213</fpage>
            <page-range>3213-3219</page-range>
            <pub-id pub-id-type="pmid">33896860</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jun</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Jeon</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Um</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Kwon</surname>
                <given-names>OJ</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>NY</given-names>
              </name>
              <name>
                <surname>Koh</surname>
                <given-names>WJ</given-names>
              </name>
            </person-group>
            <article-title>Nontuberculous mycobacteria isolated during the treatment of pulmonary tuberculosis.</article-title>
            <source>Respir Med</source>
            <year>2009</year>
            <month>Dec</month>
            <volume>103</volume>
            <issue>12</issue>
            <fpage>1936</fpage>
            <page-range>1936-40</page-range>
            <pub-id pub-id-type="pmid">19576745</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chaptal</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Andrejak</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bonifay</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Beillard</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Guillot</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Guyomard-Rabenirina</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Demar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Trombert-Paolantoni</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jacomo</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Mosnier</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Veziris</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Djossou</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Epelboin</surname>
                <given-names>L</given-names>
              </name>
              <collab>French Guiana PNTM working group</collab>
            </person-group>
            <article-title>Epidemiology of infection by pulmonary non-tuberculous mycobacteria in French Guiana 2008-2018.</article-title>
            <source>PLoS Negl Trop Dis</source>
            <year>2022</year>
            <month>Sep</month>
            <volume>16</volume>
            <issue>9</issue>
            <fpage>e0010693</fpage>
            <pub-id pub-id-type="pmid">36084148</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chindam</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Vengaldas</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Srigiri</surname>
                <given-names>VR</given-names>
              </name>
              <name>
                <surname>Syed</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Kilaru</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Chenimilla</surname>
                <given-names>NP</given-names>
              </name>
              <name>
                <surname>Kilaru</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Patil</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Challenges of diagnosing and treating non-tuberculous mycobacterial pulmonary disease [NTM-PD]: A case series.</article-title>
            <source>J Clin Tuberc Other Mycobact Dis</source>
            <year>2021</year>
            <month>Dec</month>
            <volume>25</volume>
            <fpage>100271</fpage>
            <pub-id pub-id-type="pmid">34541338</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pravosud</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Mannino</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Prieto</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Choate</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Malanga</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Aksamit</surname>
                <given-names>TR</given-names>
              </name>
            </person-group>
            <article-title>Symptom Burden and Medication Use Among Patients with Nontuberculous Mycobacterial Lung Disease.</article-title>
            <source>Chronic Obstr Pulm Dis</source>
            <year>2021</year>
            <month>Apr</month>
            <day>27</day>
            <volume>8</volume>
            <issue>2</issue>
            <fpage>243</fpage>
            <page-range>243-254</page-range>
            <pub-id pub-id-type="pmid">33610137</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Daley</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Iaccarino</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Lange</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cambau</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Andrejak</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>B&#x000f6;ttger</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Brozek</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Griffith</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Guglielmetti</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Huitt</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Knight</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Leitman</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Marras</surname>
                <given-names>TK</given-names>
              </name>
              <name>
                <surname>Olivier</surname>
                <given-names>KN</given-names>
              </name>
              <name>
                <surname>Santin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Stout</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Tortoli</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>van Ingen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wagner</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Winthrop</surname>
                <given-names>KL</given-names>
              </name>
            </person-group>
            <article-title>Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline.</article-title>
            <source>Clin Infect Dis</source>
            <year>2020</year>
            <month>Aug</month>
            <day>14</day>
            <volume>71</volume>
            <issue>4</issue>
            <fpage>e1</fpage>
            <page-range>e1-e36</page-range>
            <pub-id pub-id-type="pmid">32628747</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schildkraut</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Zweijpfenning</surname>
                <given-names>SMH</given-names>
              </name>
              <name>
                <surname>Nap</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Dacheva</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Overbeek</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tostmann</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wertheim</surname>
                <given-names>HFL</given-names>
              </name>
              <name>
                <surname>Hoefsloot</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>van Ingen</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>The epidemiology of nontuberculous mycobacterial pulmonary disease in the Netherlands.</article-title>
            <source>ERJ Open Res</source>
            <year>2021</year>
            <month>Jul</month>
            <volume>7</volume>
            <issue>3</issue>
            <pub-id pub-id-type="pmid">34262970</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thomson</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Donnan</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Konstantinos</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Notification of Nontuberculous Mycobacteria: An Australian Perspective.</article-title>
            <source>Ann Am Thorac Soc</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>14</volume>
            <issue>3</issue>
            <fpage>318</fpage>
            <page-range>318-323</page-range>
            <pub-id pub-id-type="pmid">28118021</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adjemian</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Frankland</surname>
                <given-names>TB</given-names>
              </name>
              <name>
                <surname>Daida</surname>
                <given-names>YG</given-names>
              </name>
              <name>
                <surname>Honda</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Olivier</surname>
                <given-names>KN</given-names>
              </name>
              <name>
                <surname>Zelazny</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Honda</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Prevots</surname>
                <given-names>DR</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology of Nontuberculous Mycobacterial Lung Disease and Tuberculosis, Hawaii, USA.</article-title>
            <source>Emerg Infect Dis</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>23</volume>
            <issue>3</issue>
            <fpage>439</fpage>
            <page-range>439-447</page-range>
            <pub-id pub-id-type="pmid">28221128</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Deutsch-Feldman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Springer</surname>
                <given-names>YP</given-names>
              </name>
              <name>
                <surname>Felix</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Tsang</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Brostrom</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Haddad</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Tuberculosis Among Native Hawaiian and Other Pacific Islander Persons: United States and U.S.-Affiliated Pacific Islands, 2010-2019.</article-title>
            <source>Health Equity</source>
            <year>2022</year>
            <volume>6</volume>
            <issue>1</issue>
            <fpage>476</fpage>
            <page-range>476-484</page-range>
            <pub-id pub-id-type="pmid">35801148</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lin</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Russell</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Soll</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Chow</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bamrah</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Brostrom</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Scott</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bankowski</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Increasing Prevalence of Nontuberculous Mycobacteria in Respiratory Specimens from US-Affiliated Pacific Island Jurisdictions<sup>1</sup>.</article-title>
            <source>Emerg Infect Dis</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>24</volume>
            <issue>3</issue>
            <fpage>485</fpage>
            <page-range>485-491</page-range>
            <pub-id pub-id-type="pmid">29460734</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hojo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Iikura</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hirano</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sugiyama</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kobayashi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kudo</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Increased risk of nontuberculous mycobacterial infection in asthmatic patients using long-term inhaled corticosteroid therapy.</article-title>
            <source>Respirology</source>
            <year>2012</year>
            <month>Jan</month>
            <volume>17</volume>
            <issue>1</issue>
            <fpage>185</fpage>
            <page-range>185-90</page-range>
            <pub-id pub-id-type="pmid">21995339</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>O'Brien</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Geiter</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Snider</surname>
                <given-names>DE</given-names>
              </name>
            </person-group>
            <article-title>The epidemiology of nontuberculous mycobacterial diseases in the United States. Results from a national survey.</article-title>
            <source>Am Rev Respir Dis</source>
            <year>1987</year>
            <month>May</month>
            <volume>135</volume>
            <issue>5</issue>
            <fpage>1007</fpage>
            <page-range>1007-14</page-range>
            <pub-id pub-id-type="pmid">3579001</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adjemian</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Olivier</surname>
                <given-names>KN</given-names>
              </name>
              <name>
                <surname>Seitz</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Holland</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Prevots</surname>
                <given-names>DR</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries.</article-title>
            <source>Am J Respir Crit Care Med</source>
            <year>2012</year>
            <month>Apr</month>
            <day>15</day>
            <volume>185</volume>
            <issue>8</issue>
            <fpage>881</fpage>
            <page-range>881-6</page-range>
            <pub-id pub-id-type="pmid">22312016</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shah</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Davidson</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>LF</given-names>
              </name>
              <name>
                <surname>Lalor</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>HL</given-names>
              </name>
              <name>
                <surname>Lipman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Abubakar</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Pulmonary Mycobacterium avium-intracellulare is the main driver of the rise in non-tuberculous mycobacteria incidence in England, Wales and Northern Ireland, 2007-2012.</article-title>
            <source>BMC Infect Dis</source>
            <year>2016</year>
            <month>May</month>
            <day>06</day>
            <volume>16</volume>
            <fpage>195</fpage>
            <pub-id pub-id-type="pmid">27154015</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Doh&#x000e1;l</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Porvazn&#x000ed;k</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Krivo&#x00161;ov&#x000e1;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Solovi&#x0010d;</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Mokr&#x000fd;</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology of non-tuberculous mycobacterial diseases in Slovakia during the years 2016-2021.</article-title>
            <source>Respir Physiol Neurobiol</source>
            <year>2023</year>
            <month>Aug</month>
            <volume>314</volume>
            <fpage>104090</fpage>
            <pub-id pub-id-type="pmid">37315773</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brode</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Daley</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Marras</surname>
                <given-names>TK</given-names>
              </name>
            </person-group>
            <article-title>The epidemiologic relationship between tuberculosis and non-tuberculous mycobacterial disease: a systematic review.</article-title>
            <source>Int J Tuberc Lung Dis</source>
            <year>2014</year>
            <month>Nov</month>
            <volume>18</volume>
            <issue>11</issue>
            <fpage>1370</fpage>
            <page-range>1370-7</page-range>
            <pub-id pub-id-type="pmid">25299873</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <article-title>Rapid increase of the incidence of lung disease due to Mycobacterium kansasii in Japan.</article-title>
            <source>Chest</source>
            <year>1983</year>
            <month>Jun</month>
            <volume>83</volume>
            <issue>6</issue>
            <fpage>890</fpage>
            <page-range>890-2</page-range>
            <pub-id pub-id-type="pmid">6851691</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thomson</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Furuya-Kanamori</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Coffey</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bell</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Knibbs</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Lau</surname>
                <given-names>CL</given-names>
              </name>
            </person-group>
            <article-title>Influence of climate variables on the rising incidence of nontuberculous mycobacterial (NTM) infections in Queensland, Australia 2001-2016.</article-title>
            <source>Sci Total Environ</source>
            <year>2020</year>
            <month>Oct</month>
            <day>20</day>
            <volume>740</volume>
            <fpage>139796</fpage>
            <pub-id pub-id-type="pmid">32563864</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Ju</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>You</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Jeong</surname>
                <given-names>YY</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Oh</surname>
                <given-names>YM</given-names>
              </name>
              <name>
                <surname>Ra</surname>
                <given-names>SW</given-names>
              </name>
            </person-group>
            <article-title>Trends in the Prevalence of Non-TB Mycobacterial Infection in Patients With Non-Cystic Fibrosis Bronchiectasis in South Korea, 2012-2016.</article-title>
            <source>Chest</source>
            <year>2021</year>
            <month>Mar</month>
            <volume>159</volume>
            <issue>3</issue>
            <fpage>959</fpage>
            <page-range>959-962</page-range>
            <pub-id pub-id-type="pmid">33301746</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thomson</surname>
                <given-names>RM</given-names>
              </name>
              <collab>NTM working group at Queensland TB Control Centre and Queensland Mycobacterial Reference Laboratory</collab>
            </person-group>
            <article-title>Changing epidemiology of pulmonary nontuberculous mycobacteria infections.</article-title>
            <source>Emerg Infect Dis</source>
            <year>2010</year>
            <month>Oct</month>
            <volume>16</volume>
            <issue>10</issue>
            <fpage>1576</fpage>
            <page-range>1576-83</page-range>
            <pub-id pub-id-type="pmid">20875283</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Park</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>YA</given-names>
              </name>
            </person-group>
            <article-title>Prevalence, incidence, and mortality of nontuberculous mycobacterial infection in Korea: a nationwide population-based study.</article-title>
            <source>BMC Pulm Med</source>
            <year>2019</year>
            <month>Aug</month>
            <day>01</day>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>140</fpage>
            <pub-id pub-id-type="pmid">31370826</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Falkinham</surname>
                <given-names>JO</given-names>
              </name>
            </person-group>
            <article-title>Nontuberculous mycobacteria from household plumbing of patients with nontuberculous mycobacteria disease.</article-title>
            <source>Emerg Infect Dis</source>
            <year>2011</year>
            <month>Mar</month>
            <volume>17</volume>
            <issue>3</issue>
            <fpage>419</fpage>
            <page-range>419-24</page-range>
            <pub-id pub-id-type="pmid">21392432</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shen</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Haig</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Prussin</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>LiPuma</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Marr</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Raskin</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Shower water contributes viable nontuberculous mycobacteria to indoor air.</article-title>
            <source>PNAS Nexus</source>
            <year>2022</year>
            <month>Nov</month>
            <volume>1</volume>
            <issue>5</issue>
            <fpage>pgac145</fpage>
            <pub-id pub-id-type="pmid">36712351</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dirac</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Horan</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Doody</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Meschke</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Jackson</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Weiss</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Winthrop</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Cangelosi</surname>
                <given-names>GA</given-names>
              </name>
            </person-group>
            <article-title>Environment or host?: A case-control study of risk factors for Mycobacterium avium complex lung disease.</article-title>
            <source>Am J Respir Crit Care Med</source>
            <year>2012</year>
            <month>Oct</month>
            <day>01</day>
            <volume>186</volume>
            <issue>7</issue>
            <fpage>684</fpage>
            <page-range>684-91</page-range>
            <pub-id pub-id-type="pmid">22859521</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Prevots</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Adjemian</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fernandez</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Knowles</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Olivier</surname>
                <given-names>KN</given-names>
              </name>
            </person-group>
            <article-title>Environmental risks for nontuberculous mycobacteria. Individual exposures and climatic factors in the cystic fibrosis population.</article-title>
            <source>Ann Am Thorac Soc</source>
            <year>2014</year>
            <month>Sep</month>
            <volume>11</volume>
            <issue>7</issue>
            <fpage>1032</fpage>
            <page-range>1032-8</page-range>
            <pub-id pub-id-type="pmid">25068620</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kahana</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Kay</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Yakrus</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Waserman</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Mycobacterium avium complex infection in an immunocompetent young adult related to hot tub exposure.</article-title>
            <source>Chest</source>
            <year>1997</year>
            <month>Jan</month>
            <volume>111</volume>
            <issue>1</issue>
            <fpage>242</fpage>
            <page-range>242-5</page-range>
            <pub-id pub-id-type="pmid">8996025</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cowman</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>van Ingen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Griffith</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Loebinger</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>Non-tuberculous mycobacterial pulmonary disease.</article-title>
            <source>Eur Respir J</source>
            <year>2019</year>
            <month>Jul</month>
            <volume>54</volume>
            <issue>1</issue>
            <pub-id pub-id-type="pmid">31221809</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garcia</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Wilmskoetter</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Grady</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mingora</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Dorman</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Flume</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Chest Computed Tomography Features of Nontuberculous Mycobacterial Pulmonary Disease Versus Asymptomatic Colonization: A Cross-sectional Cohort Study.</article-title>
            <source>J Thorac Imaging</source>
            <year>2022</year>
            <month>May</month>
            <day>01</day>
            <volume>37</volume>
            <issue>3</issue>
            <fpage>140</fpage>
            <page-range>140-145</page-range>
            <pub-id pub-id-type="pmid">34292274</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fowler</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>French</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Screaton</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Foweraker</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Condliffe</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Haworth</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Exley</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Bilton</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Nontuberculous mycobacteria in bronchiectasis: Prevalence and patient characteristics.</article-title>
            <source>Eur Respir J</source>
            <year>2006</year>
            <month>Dec</month>
            <volume>28</volume>
            <issue>6</issue>
            <fpage>1204</fpage>
            <page-range>1204-10</page-range>
            <pub-id pub-id-type="pmid">16807259</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bai</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Bai</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Honda</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Eichstaedt</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Musheyev</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Feng</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Huitt</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Harbeck</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kosmider</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Sandhaus</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>ED</given-names>
              </name>
            </person-group>
            <article-title>Alpha-1-Antitrypsin Enhances Primary Human Macrophage Immunity Against Non-tuberculous Mycobacteria.</article-title>
            <source>Front Immunol</source>
            <year>2019</year>
            <volume>10</volume>
            <fpage>1417</fpage>
            <pub-id pub-id-type="pmid">31293581</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wijers</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Chmiel</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Gaston</surname>
                <given-names>BM</given-names>
              </name>
            </person-group>
            <article-title>Bacterial infections in patients with primary ciliary dyskinesia: Comparison with cystic fibrosis.</article-title>
            <source>Chron Respir Dis</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>14</volume>
            <issue>4</issue>
            <fpage>392</fpage>
            <page-range>392-406</page-range>
            <pub-id pub-id-type="pmid">29081265</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Benmerzoug</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Marinho</surname>
                <given-names>FV</given-names>
              </name>
              <name>
                <surname>Rose</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mackowiak</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gosset</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Sedda</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Poisson</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Uyttenhove</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Van Snick</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jacobs</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Garcia</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Ryffel</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Quesniaux</surname>
                <given-names>VFJ</given-names>
              </name>
            </person-group>
            <article-title>GM-CSF targeted immunomodulation affects host response to M. tuberculosis infection.</article-title>
            <source>Sci Rep</source>
            <year>2018</year>
            <month>Jun</month>
            <day>05</day>
            <volume>8</volume>
            <issue>1</issue>
            <fpage>8652</fpage>
            <pub-id pub-id-type="pmid">29872095</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lombardi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Villa</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Castelli</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Bandera</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gori</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>T-Cell Exhaustion in <italic>Mycobacterium tuberculosis</italic> and Nontuberculous Mycobacteria Infection: Pathophysiology and Therapeutic Perspectives.</article-title>
            <source>Microorganisms</source>
            <year>2021</year>
            <month>Nov</month>
            <day>28</day>
            <volume>9</volume>
            <issue>12</issue>
            <pub-id pub-id-type="pmid">34946062</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McCarthy</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Cain</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Winthrop</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Udomsantisuk</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Lan</surname>
                <given-names>NT</given-names>
              </name>
              <name>
                <surname>Sar</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kimerling</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Kanara</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Lynen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Monkongdee</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Tasaneeyapan</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Varma</surname>
                <given-names>JK</given-names>
              </name>
            </person-group>
            <article-title>Nontuberculous mycobacterial disease in patients with HIV in Southeast Asia.</article-title>
            <source>Am J Respir Crit Care Med</source>
            <year>2012</year>
            <month>May</month>
            <day>01</day>
            <volume>185</volume>
            <issue>9</issue>
            <fpage>981</fpage>
            <page-range>981-8</page-range>
            <pub-id pub-id-type="pmid">22345581</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Horsburgh</surname>
                <given-names>CR</given-names>
              </name>
            </person-group>
            <article-title>Mycobacterium avium complex infection in the acquired immunodeficiency syndrome.</article-title>
            <source>N Engl J Med</source>
            <year>1991</year>
            <month>May</month>
            <day>09</day>
            <volume>324</volume>
            <issue>19</issue>
            <fpage>1332</fpage>
            <page-range>1332-8</page-range>
            <pub-id pub-id-type="pmid">2017230</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maglione</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>B cells moderate inflammatory progression and enhance bacterial containment upon pulmonary challenge with Mycobacterium tuberculosis.</article-title>
            <source>J Immunol</source>
            <year>2007</year>
            <month>Jun</month>
            <day>01</day>
            <volume>178</volume>
            <issue>11</issue>
            <fpage>7222</fpage>
            <page-range>7222-34</page-range>
            <pub-id pub-id-type="pmid">17513771</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lutt</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Pisculli</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Weinblatt</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Deodhar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Winthrop</surname>
                <given-names>KL</given-names>
              </name>
            </person-group>
            <article-title>Severe nontuberculous mycobacterial infection in 2 patients receiving rituximab for refractory myositis.</article-title>
            <source>J Rheumatol</source>
            <year>2008</year>
            <month>Aug</month>
            <volume>35</volume>
            <issue>8</issue>
            <fpage>1683</fpage>
            <page-range>1683-5</page-range>
            <pub-id pub-id-type="pmid">18671331</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Okumura</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Iwai</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ogata</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ueyama</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kubota</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Aoki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kokuto</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Tadokoro</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Uchiyama</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Saotome</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yoshiyama</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Yoshimori</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Yoshida</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Azuma</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kudoh</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Clinical factors on cavitary and nodular bronchiectatic types in pulmonary Mycobacterium avium complex disease.</article-title>
            <source>Intern Med</source>
            <year>2008</year>
            <volume>47</volume>
            <issue>16</issue>
            <fpage>1465</fpage>
            <page-range>1465-72</page-range>
            <pub-id pub-id-type="pmid">18703856</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chan</surname>
                <given-names>ED</given-names>
              </name>
              <name>
                <surname>Iseman</surname>
                <given-names>MD</given-names>
              </name>
            </person-group>
            <article-title>Slender, older women appear to be more susceptible to nontuberculous mycobacterial lung disease.</article-title>
            <source>Gend Med</source>
            <year>2010</year>
            <month>Feb</month>
            <volume>7</volume>
            <issue>1</issue>
            <fpage>5</fpage>
            <page-range>5-18</page-range>
            <pub-id pub-id-type="pmid">20189150</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Iseman</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Buschman</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Ackerson</surname>
                <given-names>LM</given-names>
              </name>
            </person-group>
            <article-title>Pectus excavatum and scoliosis. Thoracic anomalies associated with pulmonary disease caused by Mycobacterium avium complex.</article-title>
            <source>Am Rev Respir Dis</source>
            <year>1991</year>
            <month>Oct</month>
            <volume>144</volume>
            <issue>4</issue>
            <fpage>914</fpage>
            <page-range>914-6</page-range>
            <pub-id pub-id-type="pmid">1928970</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dawrs</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Kautz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>ED</given-names>
              </name>
              <name>
                <surname>Honda</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title><italic>Mycobacterium</italic><italic>abscessus</italic> and Gastroesophageal Reflux: An <italic>In Vitro</italic> Study.</article-title>
            <source>Am J Respir Crit Care Med</source>
            <year>2020</year>
            <month>Aug</month>
            <day>01</day>
            <volume>202</volume>
            <issue>3</issue>
            <fpage>466</fpage>
            <page-range>466-469</page-range>
            <pub-id pub-id-type="pmid">32298605</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Koh</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Kwon</surname>
                <given-names>OJ</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>KS</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and treatment of nontuberculous mycobacterial pulmonary diseases: a Korean perspective.</article-title>
            <source>J Korean Med Sci</source>
            <year>2005</year>
            <month>Dec</month>
            <volume>20</volume>
            <issue>6</issue>
            <fpage>913</fpage>
            <page-range>913-25</page-range>
            <pub-id pub-id-type="pmid">16361797</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thomson</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Tolson</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Carter</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Coulter</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Huygens</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Hargreaves</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Isolation of nontuberculous mycobacteria (NTM) from household water and shower aerosols in patients with pulmonary disease caused by NTM.</article-title>
            <source>J Clin Microbiol</source>
            <year>2013</year>
            <month>Sep</month>
            <volume>51</volume>
            <issue>9</issue>
            <fpage>3006</fpage>
            <page-range>3006-11</page-range>
            <pub-id pub-id-type="pmid">23843489</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thomson</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Carter</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Tolson</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Coulter</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Huygens</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Hargreaves</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Factors associated with the isolation of Nontuberculous mycobacteria (NTM) from a large municipal water system in Brisbane, Australia.</article-title>
            <source>BMC Microbiol</source>
            <year>2013</year>
            <month>Apr</month>
            <day>22</day>
            <volume>13</volume>
            <fpage>89</fpage>
            <pub-id pub-id-type="pmid">23601969</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pennington</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Vu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Challener</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Rivera</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Shweta</surname>
                <given-names>FNU</given-names>
              </name>
              <name>
                <surname>Zeuli</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Temesgen</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Approach to the diagnosis and treatment of non-tuberculous mycobacterial disease.</article-title>
            <source>J Clin Tuberc Other Mycobact Dis</source>
            <year>2021</year>
            <month>Aug</month>
            <volume>24</volume>
            <fpage>100244</fpage>
            <pub-id pub-id-type="pmid">34036184</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pathak</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hart</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lande</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Nontuberculous Mycobacteria Lung Disease (NTM-LD): Current Recommendations on Diagnosis, Treatment, and Patient Management.</article-title>
            <source>Int J Gen Med</source>
            <year>2022</year>
            <volume>15</volume>
            <fpage>7619</fpage>
            <page-range>7619-7629</page-range>
            <pub-id pub-id-type="pmid">36213301</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kendall</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Varley</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Cassidy</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Hedberg</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ware</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Winthrop</surname>
                <given-names>KL</given-names>
              </name>
            </person-group>
            <article-title>Distinguishing tuberculosis from nontuberculous mycobacteria lung disease, Oregon, USA.</article-title>
            <source>Emerg Infect Dis</source>
            <year>2011</year>
            <month>Mar</month>
            <volume>17</volume>
            <issue>3</issue>
            <fpage>506</fpage>
            <page-range>506-9</page-range>
            <pub-id pub-id-type="pmid">21392445</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gopalaswamy</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Shanmugam</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mondal</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Subbian</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Of tuberculosis and non-tuberculous mycobacterial infections - a comparative analysis of epidemiology, diagnosis and treatment.</article-title>
            <source>J Biomed Sci</source>
            <year>2020</year>
            <month>Jun</month>
            <day>17</day>
            <volume>27</volume>
            <issue>1</issue>
            <fpage>74</fpage>
            <pub-id pub-id-type="pmid">32552732</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Musaddaq</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Cleverley</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis of non-tuberculous mycobacterial pulmonary disease (NTM-PD): modern challenges.</article-title>
            <source>Br J Radiol</source>
            <year>2020</year>
            <month>Feb</month>
            <day>01</day>
            <volume>93</volume>
            <issue>1106</issue>
            <fpage>20190768</fpage>
            <pub-id pub-id-type="pmid">31794241</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Parkar</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Kandiah</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Differential Diagnosis of Cavitary Lung Lesions.</article-title>
            <source>J Belg Soc Radiol</source>
            <year>2016</year>
            <month>Nov</month>
            <day>19</day>
            <volume>100</volume>
            <issue>1</issue>
            <fpage>100</fpage>
            <pub-id pub-id-type="pmid">30151493</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kartalija</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ovrutsky</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Bryan</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Pott</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Fantuzzi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Strand</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Bai</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Ramamoorthy</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rothman</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Nagabhushanam</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>McDermott</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Levin</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Frazer-Abel</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Giclas</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Korner</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Iseman</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Shapiro</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>ED</given-names>
              </name>
            </person-group>
            <article-title>Patients with nontuberculous mycobacterial lung disease exhibit unique body and immune phenotypes.</article-title>
            <source>Am J Respir Crit Care Med</source>
            <year>2013</year>
            <month>Jan</month>
            <day>15</day>
            <volume>187</volume>
            <issue>2</issue>
            <fpage>197</fpage>
            <page-range>197-205</page-range>
            <pub-id pub-id-type="pmid">23144328</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Xiao</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gui</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Gong</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of nontuberculous mycobacteria in patients with bronchiectasis: a meta-analysis.</article-title>
            <source>Arch Med Sci</source>
            <year>2014</year>
            <month>Aug</month>
            <day>29</day>
            <volume>10</volume>
            <issue>4</issue>
            <fpage>661</fpage>
            <page-range>661-8</page-range>
            <pub-id pub-id-type="pmid">25276148</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pursner</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Haller</surname>
                <given-names>JO</given-names>
              </name>
              <name>
                <surname>Berdon</surname>
                <given-names>WE</given-names>
              </name>
            </person-group>
            <article-title>Imaging features of Mycobacterium avium-intracellulare complex (MAC) in children with AIDS.</article-title>
            <source>Pediatr Radiol</source>
            <year>2000</year>
            <month>Jun</month>
            <volume>30</volume>
            <issue>6</issue>
            <fpage>426</fpage>
            <page-range>426-9</page-range>
            <pub-id pub-id-type="pmid">10876832</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Soetaert</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Subissi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ceyssens</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Vanfleteren</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Chantrenne</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Asikainen</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Duysburgh</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mathys</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Strong increase of true and false positive mycobacterial cultures sent to the National Reference Centre in Belgium, 2007 to 2016.</article-title>
            <source>Euro Surveill</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>24</volume>
            <issue>11</issue>
            <pub-id pub-id-type="pmid">30892180</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r74">
          <label>74</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Yi</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>CL</given-names>
              </name>
            </person-group>
            <article-title>Recovery Rates of Non-Tuberculous Mycobacteria from Clinical Specimens Are Increasing in Korean Tertiary-Care Hospitals.</article-title>
            <source>J Korean Med Sci</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>32</volume>
            <issue>8</issue>
            <fpage>1263</fpage>
            <page-range>1263-1267</page-range>
            <pub-id pub-id-type="pmid">28665061</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r75">
          <label>75</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Somosk&#x000f6;vi A</surname>
              </name>
              <name>
                <surname>Hotaling</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Fitzgerald</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>O'Donnell</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Parsons</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Salfinger</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Lessons from a proficiency testing event for acid-fast microscopy.</article-title>
            <source>Chest</source>
            <year>2001</year>
            <month>Jul</month>
            <volume>120</volume>
            <issue>1</issue>
            <fpage>250</fpage>
            <page-range>250-7</page-range>
            <pub-id pub-id-type="pmid">11451846</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r76">
          <label>76</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sawatpanich</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Petsong</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tumwasorn</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rotcheewaphan</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic performance of the Anyplex MTB/NTM real-time PCR in detection of <italic>Mycobacterium tuberculosis</italic> complex and nontuberculous mycobacteria from pulmonary and extrapulmonary specimens.</article-title>
            <source>Heliyon</source>
            <year>2022</year>
            <month>Dec</month>
            <volume>8</volume>
            <issue>12</issue>
            <fpage>e11935</fpage>
            <pub-id pub-id-type="pmid">36471833</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r77">
          <label>77</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alonso</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Samper</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mart&#x000ed;n</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Otal</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Mapping IS6110 in high-copy number Mycobacterium tuberculosis strains shows specific insertion points in the Beijing genotype.</article-title>
            <source>BMC Genomics</source>
            <year>2013</year>
            <month>Jun</month>
            <day>25</day>
            <volume>14</volume>
            <fpage>422</fpage>
            <pub-id pub-id-type="pmid">23800083</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r78">
          <label>78</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Harboe</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nagai</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Patarroyo</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Torres</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Ramirez</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cruz</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Properties of proteins MPB64, MPB70, and MPB80 of Mycobacterium bovis BCG.</article-title>
            <source>Infect Immun</source>
            <year>1986</year>
            <month>Apr</month>
            <volume>52</volume>
            <issue>1</issue>
            <fpage>293</fpage>
            <page-range>293-302</page-range>
            <pub-id pub-id-type="pmid">3514457</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r79">
          <label>79</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alexander</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Furlong</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Baron</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Rihs</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Stephenson</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Perry</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Stout</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of a new culture medium for isolation of nontuberculous mycobacteria from environmental water samples.</article-title>
            <source>PLoS One</source>
            <year>2021</year>
            <volume>16</volume>
            <issue>3</issue>
            <fpage>e0247166</fpage>
            <pub-id pub-id-type="pmid">33657154</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r80">
          <label>80</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ryu</surname>
                <given-names>YJ</given-names>
              </name>
              <name>
                <surname>Koh</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Daley</surname>
                <given-names>CL</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and Treatment of Nontuberculous Mycobacterial Lung Disease: Clinicians' Perspectives.</article-title>
            <source>Tuberc Respir Dis (Seoul)</source>
            <year>2016</year>
            <month>Apr</month>
            <volume>79</volume>
            <issue>2</issue>
            <fpage>74</fpage>
            <page-range>74-84</page-range>
            <pub-id pub-id-type="pmid">27066084</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r81">
          <label>81</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Caverly</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Carmody</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Haig</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Kotlarz</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kalikin</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Raskin</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>LiPuma</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Culture-Independent Identification of Nontuberculous Mycobacteria in Cystic Fibrosis Respiratory Samples.</article-title>
            <source>PLoS One</source>
            <year>2016</year>
            <volume>11</volume>
            <issue>4</issue>
            <fpage>e0153876</fpage>
            <pub-id pub-id-type="pmid">27093603</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r82">
          <label>82</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Im</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Hwang</surname>
                <given-names>NY</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kwon</surname>
                <given-names>OJ</given-names>
              </name>
              <name>
                <surname>Jhun</surname>
                <given-names>BW</given-names>
              </name>
            </person-group>
            <article-title>Impact of Time Between Diagnosis and Treatment for Nontuberculous Mycobacterial Pulmonary Disease on Culture Conversion and All-Cause Mortality.</article-title>
            <source>Chest</source>
            <year>2022</year>
            <month>May</month>
            <volume>161</volume>
            <issue>5</issue>
            <fpage>1192</fpage>
            <page-range>1192-1200</page-range>
            <pub-id pub-id-type="pmid">34793759</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r83">
          <label>83</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Doh&#x000e1;l</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Porvazn&#x000ed;k</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Solovi&#x0010d;</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Mokr&#x000fd;</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Whole Genome Sequencing in the Management of Non-Tuberculous Mycobacterial Infections.</article-title>
            <source>Microorganisms</source>
            <year>2021</year>
            <month>Oct</month>
            <day>27</day>
            <volume>9</volume>
            <issue>11</issue>
            <pub-id pub-id-type="pmid">34835363</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r84">
          <label>84</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Donnan</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Marais</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Coulter</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Waring</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bastian</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Williamson</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Sherry</surname>
                <given-names>NL</given-names>
              </name>
              <name>
                <surname>Bond</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sintchenko</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Meumann</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Horan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Cooley</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Denholm</surname>
                <given-names>JT</given-names>
              </name>
            </person-group>
            <article-title>The use of whole genome sequencing for tuberculosis public health activities in Australia: a joint statement of the National Tuberculosis Advisory Committee and Communicable Diseases Genomics Network.</article-title>
            <source>Commun Dis Intell (2018)</source>
            <year>2023</year>
            <month>Feb</month>
            <day>28</day>
            <volume>47</volume>
            <pub-id pub-id-type="pmid">36850064</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r85">
          <label>85</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rodriguez-Temporal</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Alcaide</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Marekovi&#x00107;</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>O'Connor</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Gorton</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>van Ingen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Van den Bossche</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>H&#x000e9;ry-Arnaud</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Beauruelle</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Orth-H&#x000f6;ller</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Palacios-Guti&#x000e9;rrez</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Tud&#x000f3;</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bou</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ceyssens</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Garrig&#x000f3;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez-Martin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Greub</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Hrabak</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ingebretsen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mediavilla-Gradolph</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Ovia&#x000f1;o</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Palop</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Pranada</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Quiroga</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ruiz-Serrano</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Rodr&#x000ed;guez-S&#x000e1;nchez</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Multicentre study on the reproducibility of MALDI-TOF MS for nontuberculous mycobacteria identification.</article-title>
            <source>Sci Rep</source>
            <year>2022</year>
            <month>Jan</month>
            <day>24</day>
            <volume>12</volume>
            <issue>1</issue>
            <fpage>1237</fpage>
            <pub-id pub-id-type="pmid">35075208</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r86">
          <label>86</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Johnson</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Byrd</surname>
                <given-names>TF</given-names>
              </name>
              <name>
                <surname>Drummond</surname>
                <given-names>WK</given-names>
              </name>
              <name>
                <surname>Childs-Kean</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Mahoney</surname>
                <given-names>MV</given-names>
              </name>
              <name>
                <surname>Pearson</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Rivera</surname>
                <given-names>CG</given-names>
              </name>
            </person-group>
            <article-title>Contemporary Pharmacotherapies for Nontuberculosis Mycobacterial Infections: A Narrative Review.</article-title>
            <source>Infect Dis Ther</source>
            <year>2023</year>
            <month>Feb</month>
            <volume>12</volume>
            <issue>2</issue>
            <fpage>343</fpage>
            <page-range>343-365</page-range>
            <pub-id pub-id-type="pmid">36609820</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r87">
          <label>87</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kwon</surname>
                <given-names>YS</given-names>
              </name>
              <name>
                <surname>Koh</surname>
                <given-names>WJ</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and Treatment of Nontuberculous Mycobacterial Lung Disease.</article-title>
            <source>J Korean Med Sci</source>
            <year>2016</year>
            <month>May</month>
            <volume>31</volume>
            <issue>5</issue>
            <fpage>649</fpage>
            <page-range>649-59</page-range>
            <pub-id pub-id-type="pmid">27134484</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r88">
          <label>88</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Richard</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Guti&#x000e9;rrez</surname>
                <given-names>AV</given-names>
              </name>
              <name>
                <surname>Kremer</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Dissecting <italic>erm</italic>(41)-Mediated Macrolide-Inducible Resistance in Mycobacterium abscessus.</article-title>
            <source>Antimicrob Agents Chemother</source>
            <year>2020</year>
            <month>Jan</month>
            <day>27</day>
            <volume>64</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">31791943</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r89">
          <label>89</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lyu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jang</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Oh</surname>
                <given-names>YM</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>WS</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Shim</surname>
                <given-names>TS</given-names>
              </name>
            </person-group>
            <article-title>Outcomes in patients with Mycobacterium abscessus pulmonary disease treated with long-term injectable drugs.</article-title>
            <source>Respir Med</source>
            <year>2011</year>
            <month>May</month>
            <volume>105</volume>
            <issue>5</issue>
            <fpage>781</fpage>
            <page-range>781-7</page-range>
            <pub-id pub-id-type="pmid">21211956</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r90">
          <label>90</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gill</surname>
                <given-names>LI</given-names>
              </name>
              <name>
                <surname>Dominic</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tiberi</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Atypical mycobacterial infections - management and when to treat.</article-title>
            <source>Curr Opin Pulm Med</source>
            <year>2021</year>
            <month>May</month>
            <day>01</day>
            <volume>27</volume>
            <issue>3</issue>
            <fpage>216</fpage>
            <page-range>216-223</page-range>
            <pub-id pub-id-type="pmid">33560672</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r91">
          <label>91</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Griffith</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Eagle</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Thomson</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Aksamit</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Hasegawa</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Morimoto</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Addrizzo-Harris</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>O'Donnell</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Marras</surname>
                <given-names>TK</given-names>
              </name>
              <name>
                <surname>Flume</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Loebinger</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Morgan</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Codecasa</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>Hill</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Ruoss</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Yim</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Ringshausen</surname>
                <given-names>FC</given-names>
              </name>
              <name>
                <surname>Field</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Philley</surname>
                <given-names>JV</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>van Ingen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Coulter</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Nezamis</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Winthrop</surname>
                <given-names>KL</given-names>
              </name>
              <collab>CONVERT Study Group</collab>
            </person-group>
            <article-title>Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by <italic>Mycobacterium avium</italic> Complex (CONVERT). A Prospective, Open-Label, Randomized Study.</article-title>
            <source>Am J Respir Crit Care Med</source>
            <year>2018</year>
            <month>Dec</month>
            <day>15</day>
            <volume>198</volume>
            <issue>12</issue>
            <fpage>1559</fpage>
            <page-range>1559-1569</page-range>
            <pub-id pub-id-type="pmid">30216086</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r92">
          <label>92</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Martiniano</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Esther</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Haworth</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Kasperbauer</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Zemanick</surname>
                <given-names>ET</given-names>
              </name>
              <name>
                <surname>Caverly</surname>
                <given-names>LJ</given-names>
              </name>
            </person-group>
            <article-title>Challenging scenarios in nontuberculous mycobacterial infection in cystic fibrosis.</article-title>
            <source>Pediatr Pulmonol</source>
            <year>2020</year>
            <month>Feb</month>
            <volume>55</volume>
            <issue>2</issue>
            <fpage>521</fpage>
            <page-range>521-525</page-range>
            <pub-id pub-id-type="pmid">31821718</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r93">
          <label>93</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ballarino</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Olivier</surname>
                <given-names>KN</given-names>
              </name>
              <name>
                <surname>Claypool</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Holland</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Prevots</surname>
                <given-names>DR</given-names>
              </name>
            </person-group>
            <article-title>Pulmonary nontuberculous mycobacterial infections: antibiotic treatment and associated costs.</article-title>
            <source>Respir Med</source>
            <year>2009</year>
            <month>Oct</month>
            <volume>103</volume>
            <issue>10</issue>
            <fpage>1448</fpage>
            <page-range>1448-55</page-range>
            <pub-id pub-id-type="pmid">19467851</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r94">
          <label>94</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jo</surname>
                <given-names>KW</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>WS</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Shim</surname>
                <given-names>TS</given-names>
              </name>
            </person-group>
            <article-title>Treatment outcomes of refractory MAC pulmonary disease treated with drugs with unclear efficacy.</article-title>
            <source>J Infect Chemother</source>
            <year>2014</year>
            <month>Oct</month>
            <volume>20</volume>
            <issue>10</issue>
            <fpage>602</fpage>
            <page-range>602-6</page-range>
            <pub-id pub-id-type="pmid">24981714</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r95">
          <label>95</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Hill</surname>
                <given-names>AT</given-names>
              </name>
            </person-group>
            <article-title>Amikacin liposome inhalation suspension as a treatment for patients with refractory mycobacterium avium complex lung infection.</article-title>
            <source>Expert Rev Respir Med</source>
            <year>2021</year>
            <month>Jun</month>
            <volume>15</volume>
            <issue>6</issue>
            <fpage>737</fpage>
            <page-range>737-744</page-range>
            <pub-id pub-id-type="pmid">34039231</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r96">
          <label>96</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Santin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dorca</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Alcaide</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Gonzalez</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Casas</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lopez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Guerra</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>Long-term relapses after 12-month treatment for Mycobacterium kansasii lung disease.</article-title>
            <source>Eur Respir J</source>
            <year>2009</year>
            <month>Jan</month>
            <volume>33</volume>
            <issue>1</issue>
            <fpage>148</fpage>
            <page-range>148-52</page-range>
            <pub-id pub-id-type="pmid">19118226</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r97">
          <label>97</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Sheng</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Hung</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>LN</given-names>
              </name>
              <name>
                <surname>Hsueh</surname>
                <given-names>PR</given-names>
              </name>
            </person-group>
            <article-title>Mycobacterium abscessus Complex Infections in Humans.</article-title>
            <source>Emerg Infect Dis</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>21</volume>
            <issue>9</issue>
            <fpage>1638</fpage>
            <page-range>1638-46</page-range>
            <pub-id pub-id-type="pmid">26295364</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r98">
          <label>98</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yang</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Jhun</surname>
                <given-names>BW</given-names>
              </name>
              <name>
                <surname>Moon</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>HY</given-names>
              </name>
              <name>
                <surname>Jeon</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Shin</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Daley</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Koh</surname>
                <given-names>WJ</given-names>
              </name>
            </person-group>
            <article-title>Clofazimine-Containing Regimen for the Treatment of Mycobacterium abscessus Lung Disease.</article-title>
            <source>Antimicrob Agents Chemother</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>61</volume>
            <issue>6</issue>
            <pub-id pub-id-type="pmid">28348153</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r99">
          <label>99</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Winthrop</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Ku</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Marras</surname>
                <given-names>TK</given-names>
              </name>
              <name>
                <surname>Griffith</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Daley</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Olivier</surname>
                <given-names>KN</given-names>
              </name>
              <name>
                <surname>Aksamit</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Varley</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Mackey</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Prevots</surname>
                <given-names>DR</given-names>
              </name>
            </person-group>
            <article-title>The tolerability of linezolid in the treatment of nontuberculous mycobacterial disease.</article-title>
            <source>Eur Respir J</source>
            <year>2015</year>
            <month>Apr</month>
            <volume>45</volume>
            <issue>4</issue>
            <fpage>1177</fpage>
            <page-range>1177-9</page-range>
            <pub-id pub-id-type="pmid">25614169</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r100">
          <label>100</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Inoue</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tsunoda</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nishimoto</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Nishida</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Komatsubara</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Onoe</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Saji</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mineshita</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Successful use of linezolid for refractory <italic>Mycobacterium abcessus</italic> infection: A case report.</article-title>
            <source>Respir Med Case Rep</source>
            <year>2018</year>
            <volume>23</volume>
            <fpage>43</fpage>
            <page-range>43-45</page-range>
            <pub-id pub-id-type="pmid">29234594</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r101">
          <label>101</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Siegel</surname>
                <given-names>SAR</given-names>
              </name>
              <name>
                <surname>Griffith</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Philley</surname>
                <given-names>JV</given-names>
              </name>
              <name>
                <surname>Brown-Elliott</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Brunton</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Sullivan</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Fuss</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Strnad</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Winthrop</surname>
                <given-names>KL</given-names>
              </name>
            </person-group>
            <article-title>Open-Label Trial of Amikacin Liposome Inhalation Suspension in Mycobacterium abscessus Lung Disease.</article-title>
            <source>Chest</source>
            <year>2023</year>
            <month>Oct</month>
            <volume>164</volume>
            <issue>4</issue>
            <fpage>846</fpage>
            <page-range>846-859</page-range>
            <pub-id pub-id-type="pmid">37419144</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r102">
          <label>102</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hansen</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Scott</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>McCullough</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Thorning</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Aronson</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Beller</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Glasziou</surname>
                <given-names>PP</given-names>
              </name>
              <name>
                <surname>Hoffmann</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Clark</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Del Mar</surname>
                <given-names>CB</given-names>
              </name>
            </person-group>
            <article-title>Adverse events in people taking macrolide antibiotics versus placebo for any indication.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2019</year>
            <month>Jan</month>
            <day>18</day>
            <volume>1</volume>
            <issue>1</issue>
            <fpage>CD011825</fpage>
            <pub-id pub-id-type="pmid">30656650</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r103">
          <label>103</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mosholder</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Mathew</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Alexander</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Nambiar</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Cardiovascular risks with azithromycin and other antibacterial drugs.</article-title>
            <source>N Engl J Med</source>
            <year>2013</year>
            <month>May</month>
            <day>02</day>
            <volume>368</volume>
            <issue>18</issue>
            <fpage>1665</fpage>
            <page-range>1665-8</page-range>
            <pub-id pub-id-type="pmid">23635046</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r104">
          <label>104</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vasquez</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Maddux</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Sanchez</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pollak</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Clinically significant hearing loss in renal allograft recipients treated with intravenous erythromycin.</article-title>
            <source>Arch Intern Med</source>
            <year>1993</year>
            <month>Apr</month>
            <day>12</day>
            <volume>153</volume>
            <issue>7</issue>
            <fpage>879</fpage>
            <page-range>879-82</page-range>
            <pub-id pub-id-type="pmid">8466379</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r105">
          <label>105</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barbieri</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Cicala</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cutroneo</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Mocciaro</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Sottosanti</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Freni</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Galletti</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Arcoraci</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Spina</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Ototoxic Adverse Drug Reactions: A Disproportionality Analysis Using the Italian Spontaneous Reporting Database.</article-title>
            <source>Front Pharmacol</source>
            <year>2019</year>
            <volume>10</volume>
            <fpage>1161</fpage>
            <pub-id pub-id-type="pmid">31649536</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r106">
          <label>106</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nakajima</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fukami</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kobayashi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Watanabe</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nakajima</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yokoi</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Human arylacetamide deacetylase is responsible for deacetylation of rifamycins: rifampicin, rifabutin, and rifapentine.</article-title>
            <source>Biochem Pharmacol</source>
            <year>2011</year>
            <month>Dec</month>
            <day>01</day>
            <volume>82</volume>
            <issue>11</issue>
            <fpage>1747</fpage>
            <page-range>1747-56</page-range>
            <pub-id pub-id-type="pmid">21856291</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r107">
          <label>107</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Huang</surname>
                <given-names>YS</given-names>
              </name>
              <name>
                <surname>Chern</surname>
                <given-names>HD</given-names>
              </name>
              <name>
                <surname>Su</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Chiang</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>FY</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SD</given-names>
              </name>
            </person-group>
            <article-title>Cytochrome P450 2E1 genotype and the susceptibility to antituberculosis drug-induced hepatitis.</article-title>
            <source>Hepatology</source>
            <year>2003</year>
            <month>Apr</month>
            <volume>37</volume>
            <issue>4</issue>
            <fpage>924</fpage>
            <page-range>924-30</page-range>
            <pub-id pub-id-type="pmid">12668988</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r108">
          <label>108</label>
          <element-citation publication-type="book">
            <chapter-title>Rifampin</chapter-title>
            <source>Drugs and Lactation Database (LactMed&#x000ae;) [Internet]</source>
            <publisher-name>National Institute of Child Health and Human Development</publisher-name>
            <publisher-loc>Bethesda (MD)</publisher-loc>
            <year>2024</year>
            <month>8</month>
            <day>15</day>
            <pub-id pub-id-type="pmid">30000407</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r109">
          <label>109</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Holdiness</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>A review of the Redman syndrome and rifampicin overdosage.</article-title>
            <source>Med Toxicol Adverse Drug Exp</source>
            <year>1989</year>
            <season>Nov-Dec</season>
            <volume>4</volume>
            <issue>6</issue>
            <fpage>444</fpage>
            <page-range>444-51</page-range>
            <pub-id pub-id-type="pmid">2689837</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r110">
          <label>110</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Moon</surname>
                <given-names>JI</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Ye</surname>
                <given-names>YM</given-names>
              </name>
              <name>
                <surname>Yim</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Cutaneous leukocytoclastic vasculitis due to anti-tuberculosis medications, rifampin and pyrazinamide.</article-title>
            <source>Allergy Asthma Immunol Res</source>
            <year>2010</year>
            <month>Jan</month>
            <volume>2</volume>
            <issue>1</issue>
            <fpage>55</fpage>
            <page-range>55-8</page-range>
            <pub-id pub-id-type="pmid">20224679</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r111">
          <label>111</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mehta</surname>
                <given-names>YS</given-names>
              </name>
              <name>
                <surname>Jijina</surname>
                <given-names>FF</given-names>
              </name>
              <name>
                <surname>Badakere</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Pathare</surname>
                <given-names>AV</given-names>
              </name>
              <name>
                <surname>Mohanty</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Rifampicin-induced immune thrombocytopenia.</article-title>
            <source>Tuber Lung Dis</source>
            <year>1996</year>
            <month>Dec</month>
            <volume>77</volume>
            <issue>6</issue>
            <fpage>558</fpage>
            <page-range>558-62</page-range>
            <pub-id pub-id-type="pmid">9039451</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r112">
          <label>112</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Venkatesan</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Pharmacokinetic drug interactions with rifampicin.</article-title>
            <source>Clin Pharmacokinet</source>
            <year>1992</year>
            <month>Jan</month>
            <volume>22</volume>
            <issue>1</issue>
            <fpage>47</fpage>
            <page-range>47-65</page-range>
            <pub-id pub-id-type="pmid">1559307</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r113">
          <label>113</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kasperbauer</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Nontuberculous Mycobacteria.</article-title>
            <source>Semin Respir Crit Care Med</source>
            <year>2021</year>
            <month>Aug</month>
            <volume>42</volume>
            <issue>4</issue>
            <fpage>567</fpage>
            <page-range>567-586</page-range>
            <pub-id pub-id-type="pmid">34261181</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r114">
          <label>114</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yu</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Pomerantz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bishop</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Weyant</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Mitchell</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Lady Windermere revisited: treatment with thoracoscopic lobectomy/segmentectomy for right middle lobe and lingular bronchiectasis associated with non-tuberculous mycobacterial disease.</article-title>
            <source>Eur J Cardiothorac Surg</source>
            <year>2011</year>
            <month>Sep</month>
            <volume>40</volume>
            <issue>3</issue>
            <fpage>671</fpage>
            <page-range>671-5</page-range>
            <pub-id pub-id-type="pmid">21324708</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r115">
          <label>115</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shiraishi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Katsuragi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kita</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hyogotani</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Saito</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Shimoda</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Adjuvant surgical treatment of nontuberculous mycobacterial lung disease.</article-title>
            <source>Ann Thorac Surg</source>
            <year>2013</year>
            <month>Jul</month>
            <volume>96</volume>
            <issue>1</issue>
            <fpage>287</fpage>
            <page-range>287-91</page-range>
            <pub-id pub-id-type="pmid">23618520</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r116">
          <label>116</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brode</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Marchand-Austin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jamieson</surname>
                <given-names>FB</given-names>
              </name>
              <name>
                <surname>Marras</surname>
                <given-names>TK</given-names>
              </name>
            </person-group>
            <article-title>Pulmonary versus Nonpulmonary Nontuberculous Mycobacteria, Ontario, Canada.</article-title>
            <source>Emerg Infect Dis</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>23</volume>
            <issue>11</issue>
            <fpage>1898</fpage>
            <page-range>1898-1901</page-range>
            <pub-id pub-id-type="pmid">29048292</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r117">
          <label>117</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Carpenter</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Klebsiella pulmonary infections: occurrence at one medical center and review.</article-title>
            <source>Rev Infect Dis</source>
            <year>1990</year>
            <season>Jul-Aug</season>
            <volume>12</volume>
            <issue>4</issue>
            <fpage>672</fpage>
            <page-range>672-82</page-range>
            <pub-id pub-id-type="pmid">2201068</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r118">
          <label>118</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Macfarlane</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>An overview of community acquired pneumonia with lessons learned from the British Thoracic Society Study.</article-title>
            <source>Semin Respir Infect</source>
            <year>1994</year>
            <month>Sep</month>
            <volume>9</volume>
            <issue>3</issue>
            <fpage>153</fpage>
            <page-range>153-65</page-range>
            <pub-id pub-id-type="pmid">7831537</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r119">
          <label>119</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thambidurai</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Prabhuradhan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Singhvi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ilanchezhian</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ramachandran</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Shankar</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Cryptococcal pneumonia: the great mimicker.</article-title>
            <source>BJR Case Rep</source>
            <year>2017</year>
            <volume>3</volume>
            <issue>2</issue>
            <fpage>20150358</fpage>
            <pub-id pub-id-type="pmid">30363287</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r120">
          <label>120</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sobonya</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Yanes</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Klotz</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>Cavitary pulmonary coccidioidomycosis: pathologic and clinical correlates of disease.</article-title>
            <source>Hum Pathol</source>
            <year>2014</year>
            <month>Jan</month>
            <volume>45</volume>
            <issue>1</issue>
            <fpage>153</fpage>
            <page-range>153-9</page-range>
            <pub-id pub-id-type="pmid">24321524</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r121">
          <label>121</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goodwin</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Owens</surname>
                <given-names>FT</given-names>
              </name>
              <name>
                <surname>Snell</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Hubbard</surname>
                <given-names>WW</given-names>
              </name>
              <name>
                <surname>Buchanan</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Terry</surname>
                <given-names>RT</given-names>
              </name>
              <name>
                <surname>Des Prez</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>Chronic pulmonary histoplasmosis.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>1976</year>
            <month>Nov</month>
            <volume>55</volume>
            <issue>6</issue>
            <fpage>413</fpage>
            <page-range>413-52</page-range>
            <pub-id pub-id-type="pmid">792626</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r122">
          <label>122</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Domej</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Hermann</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Krause</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Wehrsch&#x000fc;tz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Maier</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fl&#x000f6;gel</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>[Lung cavities, mycetomas and hemoptysis].</article-title>
            <source>Wien Med Wochenschr</source>
            <year>2007</year>
            <volume>157</volume>
            <issue>19-20</issue>
            <fpage>466</fpage>
            <page-range>466-72</page-range>
            <pub-id pub-id-type="pmid">18030549</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r123">
          <label>123</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gadkowski</surname>
                <given-names>LB</given-names>
              </name>
              <name>
                <surname>Stout</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Cavitary pulmonary disease.</article-title>
            <source>Clin Microbiol Rev</source>
            <year>2008</year>
            <month>Apr</month>
            <volume>21</volume>
            <issue>2</issue>
            <fpage>305</fpage>
            <page-range>305-33, table of contents</page-range>
            <pub-id pub-id-type="pmid">18400799</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r124">
          <label>124</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Myung</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Jhun</surname>
                <given-names>BW</given-names>
              </name>
            </person-group>
            <article-title>Mortality and Prognostic Factors of Nontuberculous Mycobacterial Infection in Korea: A Population-based Comparative Study.</article-title>
            <source>Clin Infect Dis</source>
            <year>2021</year>
            <month>May</month>
            <day>18</day>
            <volume>72</volume>
            <issue>10</issue>
            <fpage>e610</fpage>
            <page-range>e610-e619</page-range>
            <pub-id pub-id-type="pmid">32926135</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r125">
          <label>125</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mourad</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Baker</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Stout</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Reduction in Expected Survival Associated With Nontuberculous Mycobacterial Pulmonary Disease.</article-title>
            <source>Clin Infect Dis</source>
            <year>2021</year>
            <month>May</month>
            <day>18</day>
            <volume>72</volume>
            <issue>10</issue>
            <fpage>e552</fpage>
            <page-range>e552-e557</page-range>
            <pub-id pub-id-type="pmid">32856690</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r126">
          <label>126</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>YJ</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>YJ</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Yoon</surname>
                <given-names>HI</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>CT</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>Prognosis of nontuberculous mycobacterial pulmonary disease according to the method of microbiologic diagnosis.</article-title>
            <source>Sci Rep</source>
            <year>2021</year>
            <month>Apr</month>
            <day>13</day>
            <volume>11</volume>
            <issue>1</issue>
            <fpage>8036</fpage>
            <pub-id pub-id-type="pmid">33850204</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r127">
          <label>127</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kotilainen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Valtonen</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Tukiainen</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Poussa</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Eskola</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>J&#x000e4;rvinen</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Clinical findings in relation to mortality in non-tuberculous mycobacterial infections: patients with Mycobacterium avium complex have better survival than patients with other mycobacteria.</article-title>
            <source>Eur J Clin Microbiol Infect Dis</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>34</volume>
            <issue>9</issue>
            <fpage>1909</fpage>
            <page-range>1909-18</page-range>
            <pub-id pub-id-type="pmid">26155783</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r128">
          <label>128</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Graybill</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Silva</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fraser</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Lordon</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rogers</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Disseminated mycobacteriosis due to Mycobacterium abcessus in two recipients of renal homografts.</article-title>
            <source>Am Rev Respir Dis</source>
            <year>1974</year>
            <month>Jan</month>
            <volume>109</volume>
            <issue>1</issue>
            <fpage>4</fpage>
            <page-range>4-10</page-range>
            <pub-id pub-id-type="pmid">4588091</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r129">
          <label>129</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jhun</surname>
                <given-names>BW</given-names>
              </name>
              <name>
                <surname>Moon</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Jeon</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kwon</surname>
                <given-names>OJ</given-names>
              </name>
              <name>
                <surname>Yoo</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Carriere</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Huh</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>NY</given-names>
              </name>
              <name>
                <surname>Shin</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Daley</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Koh</surname>
                <given-names>WJ</given-names>
              </name>
            </person-group>
            <article-title>Prognostic factors associated with long-term mortality in 1445 patients with nontuberculous mycobacterial pulmonary disease: a 15-year follow-up study.</article-title>
            <source>Eur Respir J</source>
            <year>2020</year>
            <month>Jan</month>
            <volume>55</volume>
            <issue>1</issue>
            <pub-id pub-id-type="pmid">31619468</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r130">
          <label>130</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Knoll</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Kappagoda</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gill</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Goldberg</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Boyle</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Baden</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>Fuhlbrigge</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Marty</surname>
                <given-names>FM</given-names>
              </name>
            </person-group>
            <article-title>Non-tuberculous mycobacterial infection among lung transplant recipients: a 15-year cohort study.</article-title>
            <source>Transpl Infect Dis</source>
            <year>2012</year>
            <month>Oct</month>
            <volume>14</volume>
            <issue>5</issue>
            <fpage>452</fpage>
            <page-range>452-60</page-range>
            <pub-id pub-id-type="pmid">22676720</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r131">
          <label>131</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bachar</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Shulimzon</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Segel</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Nontuberculous mycobacteria infections of the pleura: A systematic review.</article-title>
            <source>Respir Med</source>
            <year>2022</year>
            <month>Dec</month>
            <volume>205</volume>
            <fpage>107036</fpage>
            <pub-id pub-id-type="pmid">36335889</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r132">
          <label>132</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khoor</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Leslie</surname>
                <given-names>KO</given-names>
              </name>
              <name>
                <surname>Tazelaar</surname>
                <given-names>HD</given-names>
              </name>
              <name>
                <surname>Helmers</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Colby</surname>
                <given-names>TV</given-names>
              </name>
            </person-group>
            <article-title>Diffuse pulmonary disease caused by nontuberculous mycobacteria in immunocompetent people (hot tub lung).</article-title>
            <source>Am J Clin Pathol</source>
            <year>2001</year>
            <month>May</month>
            <volume>115</volume>
            <issue>5</issue>
            <fpage>755</fpage>
            <page-range>755-62</page-range>
            <pub-id pub-id-type="pmid">11345841</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r133">
          <label>133</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kuroda</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Tanabe</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Igari</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sakurai</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sakao</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tada</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kasahara</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Tatsumi</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Nontuberculous mycobacterium diseases and chronic thromboembolic pulmonary hypertension.</article-title>
            <source>Intern Med</source>
            <year>2014</year>
            <volume>53</volume>
            <issue>20</issue>
            <fpage>2273</fpage>
            <page-range>2273-9</page-range>
            <pub-id pub-id-type="pmid">25318788</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r134">
          <label>134</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shah</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>McAnally</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Seoane</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Lombard</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>LaPlace</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Lick</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dhillon</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Valentine</surname>
                <given-names>VG</given-names>
              </name>
            </person-group>
            <article-title>Analysis of pulmonary non-tuberculous mycobacterial infections after lung transplantation.</article-title>
            <source>Transpl Infect Dis</source>
            <year>2016</year>
            <month>Aug</month>
            <volume>18</volume>
            <issue>4</issue>
            <fpage>585</fpage>
            <page-range>585-91</page-range>
            <pub-id pub-id-type="pmid">27368989</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r135">
          <label>135</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Olivier</surname>
                <given-names>KN</given-names>
              </name>
              <name>
                <surname>Yankaskas</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Knowles</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>Nontuberculous mycobacterial pulmonary disease in cystic fibrosis.</article-title>
            <source>Semin Respir Infect</source>
            <year>1996</year>
            <month>Dec</month>
            <volume>11</volume>
            <issue>4</issue>
            <fpage>272</fpage>
            <page-range>272-84</page-range>
            <pub-id pub-id-type="pmid">8976581</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r136">
          <label>136</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Piersimoni</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Scarparo</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Extrapulmonary infections associated with nontuberculous mycobacteria in immunocompetent persons.</article-title>
            <source>Emerg Infect Dis</source>
            <year>2009</year>
            <month>Sep</month>
            <volume>15</volume>
            <issue>9</issue>
            <fpage>1351</fpage>
            <page-range>1351-8; quiz 1544</page-range>
            <pub-id pub-id-type="pmid">19788801</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r137">
          <label>137</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zenone</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Boibieux</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tigaud</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fredenucci</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Vincent</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Chidiac</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Peyramond</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Non-tuberculous mycobacterial tenosynovitis: a review.</article-title>
            <source>Scand J Infect Dis</source>
            <year>1999</year>
            <volume>31</volume>
            <issue>3</issue>
            <fpage>221</fpage>
            <page-range>221-8</page-range>
            <pub-id pub-id-type="pmid">10482048</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r138">
          <label>138</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gasc&#x000f3;n</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sathe</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Rameshwar</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Impaired erythropoiesis in the acquired immunodeficiency syndrome with disseminated Mycobacterium avium complex.</article-title>
            <source>Am J Med</source>
            <year>1993</year>
            <month>Jan</month>
            <volume>94</volume>
            <issue>1</issue>
            <fpage>41</fpage>
            <page-range>41-8</page-range>
            <pub-id pub-id-type="pmid">8093587</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r139">
          <label>139</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Havlik</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Horsburgh</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Metchock</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>PP</given-names>
              </name>
              <name>
                <surname>Fann</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>SE</given-names>
              </name>
            </person-group>
            <article-title>Disseminated Mycobacterium avium complex infection: clinical identification and epidemiologic trends.</article-title>
            <source>J Infect Dis</source>
            <year>1992</year>
            <month>Mar</month>
            <volume>165</volume>
            <issue>3</issue>
            <fpage>577</fpage>
            <page-range>577-80</page-range>
            <pub-id pub-id-type="pmid">1347060</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r140">
          <label>140</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Davies</surname>
                <given-names>PD</given-names>
              </name>
            </person-group>
            <article-title>The role of DOTS in tuberculosis treatment and control.</article-title>
            <source>Am J Respir Med</source>
            <year>2003</year>
            <volume>2</volume>
            <issue>3</issue>
            <fpage>203</fpage>
            <page-range>203-9</page-range>
            <pub-id pub-id-type="pmid">14720002</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24517.r141">
          <label>141</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Courtney</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ballard</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Fauver</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gariota</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Holland</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>The partnership model: working with individuals, families, and communities toward a new vision of health.</article-title>
            <source>Public Health Nurs</source>
            <year>1996</year>
            <month>Jun</month>
            <volume>13</volume>
            <issue>3</issue>
            <fpage>177</fpage>
            <page-range>177-86</page-range>
            <pub-id pub-id-type="pmid">8677233</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
